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Targeted gene editing (GE) is powerful for generating genetic alterations in 
animal genomes. Programmable endonucleases such as zinc finger nucleases, 
transcription activator-like effector nucleases (TALENs) and CRISPR/Cas allow for 
GE directly in animal embryos and germ line transmission. In this thesis, procedures 
and parameters of TALEN-mediated GE of a germ line-specific gene dead end (dnd) 
in the fish medaka were examined. Embryos at the 1-cell stage were injected with 
TALEN mRNAs and examined for the survival rate and GE efficiency. Medaka 
embryos can tolerate a high dosage of TALEN-mRNA injection and exhibit a 
steadily increasing GE efficiency with the increasing of mRNA dosages until 
peaking at 100 ng/μl. This dosage produced ~24% efficiency for somatic GE. 
Several dnd GE families with various targeted alleles were established. These data 
demonstrate that TALEN is proficient for somatic and germ line GE in medaka 
embryos. 
dnd was first identified in zebrafish as a germline-specific gene that encodes an 
RNA-binding protein essential for primordial germ cell (PGC) development. dnd 
exists in many other vertebrates and is essential for gametogenesis in mouse. In this 
thesis, the role of dnd in medaka germ cell development was analyzed by 
TALEN-mediated GE. A frame-shift mutant allele containing a deletion of 10 bp in 
exon 2 of dnd was chosen as a null mutant for fish family production and phenotypic 
analyses. Embryos heterozygous for this null mutant allele were able to grow into 
adult and fertile female and male. Crossing between heterozygotes led to the 
VII 
 






) in a Mendelian manner at 
embryonic, larval and adult stages. A considerable difference in the number of PGCs 
was observed depending on the dnd genotype. At day 2 post fertilization, embryos of 
both wild type and mutant embryos reach the somitogenesis stage (6 somites). At 
this stage, a wild type embryo from a control mating between a normal male and a 
normal female has 41 PGCs on average, whereas embryos from a cross between 





averagely have 28 and 27 PGCs, whereas this number decreases significantly to 13 
in dnd
-/-
 embryos. Wild type and mutant embryos did not show a difference in the 
position of PGCs, as they were aligned dorsobilaterally to the embryonic axis 
irrespective of dnd genotype. These results demonstrate an essential role of dnd in 
PGC formation.  
Interestingly, PGCs in dnd
-/-
 embryos disappeared at day 5 post fertilization 
when PGCs were clearly visible by transgenic GFP expression and RNA in situ 




 embryos, demonstrating 
an essential role of dnd in postmigratory PGC survival. These embryos completely 
free of PGCs are able to develop into adults that possess a severely underdeveloped 
gonad and show germ cell-less sterility. These results demonstrate that medaka dnd 
is dispensable for somatic development but indispensable for germline development 
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CHAPTER 1. INTRODUCTION 
1.1.  Genome editing 
1.1.1. Overview: From gene targeting to genome editing 
Gene targeting has been the gold standard of examining a certain gene’s function. 
By completely removing a gene from the genome, gene targeting reveals what will 
happen to the organism without this gene. This way, the function of the gene can be 
convincingly demonstrated. Gene targeting utilizes homologous recombination to 
locate a specific gene out of the enormous genome by homologous sequence pairing 
and manipulates that gene in the way defined by design of the homologous sequence: 
knock-in, knock-out or both (replacement). Capecchi and his colleagues generated 
the first gene-targeted cell line in 1986 by correcting a previously introduced 
mutated neo
r
 gene (Thomas et al., 1986). Then they applied this technology on 
generating gene targeted mouse embryonic stem (ES) cells. In 1987, hprt gene was 
knocked out using a selection method that utilized the hprt gene’s own function, 
which was using 6-thioguanine to kill the cells with untargeted hprt (Thomas and 
Capecchi, 1987). The frequency of homologous recombination was around 10
-4
 
when using a targeting vector containing 14 kb of homologous sequence to target the 
hprt gene (Deng and Capecchi, 1992). Considering the ES cell line used was of male 
karyotype, it was hemizygous for hprt gene. Thus, the projected frequency of 
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homologous recombination for other genes that have two copies in the genome is 
even lower at 10
-8
. Therefore, positive and negative selection was introduced to 
enrich gene-targeted cells (Mansour et al., 1988). In detail, G418 serves as the 
positive selection that kills cells without the recombination of neo
r
-containing 
targeting vector. Gancyclovir serves as the negative selection that kills cells with the 
integration of HSV-tk gene, which is located outside the homologous recombination 
cassette on the targeting vector. 
Subsequently, they injected gene-targeted embryonic stem (ES) cells into 
developing mouse embryos to form chimera mice. Some of the gene-targeted ES 
cells were able to contribute to the germline of the embryos (Thompson et al., 1989). 
So these mice were able to produce the first batch of gene-targeted mice among their 
offspring (Chisaka et al., 1992). However, gene targeting by homologous 
recombination was not achievable for other animals for a long time. The reason is 
simple: lack of germline-competitive ES cells. Gene targeting has to be performed in 
cell lines to allow for positive and negative selection of gene-targeted clones. In the 
same time, the ES cells must be germline-competitive to allow for the production of 
gene-targeted offspring. Rat has been the only other organism to have 
germline-competitive ES cells and thus gene targeting since mouse. Qi-long Ying 
and his colleagues generated p53 knockout rats by injecting gene targeting rat ES 
cells into rat embryos in 2010, which was almost two decades since the generation of 
knockout mice (Tong et al., 2010). 
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Although germline competitive ES cell is not an option for most organisms, a 
new kind of tools emerged to bypass this prerequisite and enables gene targeting in 
almost all organisms that reproduce with embryos. They are called programmable 
endonucleases. These nucleases can be engineered to specifically target almost any 
genomic locus and create double-strand DNA breaks (DSB). Before the discovery of 
programmable endonucleases, I-SceI has been used to prove that DSB greatly 
promotes homologous recombination based gene targeting, whose inherent 
frequency is very low, in drosophila, yeast and mouse and human ES cells (Choulika 
et al., 1995; Cohen-Tannoudji et al., 1998; Donoho et al., 1998; Gloor et al., 1991; 
Smih et al., 1995). This means the programmable endonucleases can enhance the 
efficiency of gene targeting to any locus of interest by creating sequence-specific 
DSBs. Because the gene targeting efficiency has been promoted so greatly, the 
positive-negative selection procedure is no longer necessary. Therefore, 
programmable endonucleases together with desired homologous recombination 
template can be microinjected into embryos to produce gene-targeted chimeras, 
which are comparable to those generated by injecting gene-targeted 
germline-competitive ES cells. Other than homologous recombination, 
programmable endonucleases can trigger another DNA repair mechanism when no 
homologous repairing template is present, which is called non-homologous end 
joining (NHEJ). This mechanism joins the broken DNA ends in an imperfect way, 
leaving a few bps’ error. The error may disrupt the open reading frame of the target 
gene and produce knockouts of organisms. 
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With the invention of programmable nucleases, manipulation of chromosomal 
genes has been expanded a lot more than what homologous recombination based 
gene targeting was capable. Therefore, new names, such as gene editing, genome 
editing and genome engineering, have been given by the research community to 
research projects that use programmable endonucleases to manipulate genome in a 
defined manner. Detailed new approaches of genome engineering will be introduced 
after the introduction of various programmable endonucleases. 
1.1.2. Zinc finger nucleases 
Up until now, three kinds of programmable endonucleases emerged and prosper: 
zinc finger nucleases (ZFNs), transcription activator-like effector nucleases 
(TALENs) and RNA-guided engineered nucleases (RGENs) derived from the 




Zinc finger proteins are among the most abundant proteins in eukaryotic 
genomes. They consist of zinc fingers that are the most common DNA recognition 
motif in all metazoan. Zinc fingers’ structures are much diversified so that they can 
recognize equally diversified DNA sequences (Laity et al., 2001). Each zinc finger 
motif was found to bind to 3 nucleobases of DNA (Pavletich and Pabo, 1991). In 
2003, Bibikova and her colleagues first engineered a pair of ZFNs that targets gene 
yellow in drosophila, and reached a gene targeting efficiency of 2% (Bibikova et al., 
2003). Usually, three to four arrayed zinc finger motifs are fused together and tagged 
with a C-terminal FokI nuclease monomer to become a ZFN, reaching a 
sequence-recognition specificity of 9 to 12 bps (Fig. 1.1). By design, a pair of ZFNs 
will reciprocally bind to each side of the target site, spaced by several bps. This is to 
let the FokI nuclease monomers to form a dimer in between the zinc finger motifs, 
since the FokI nuclease only cut the DNA to generate a DSB after dimerization. In 
total, two ZFNs bind to 18 to 24 bps of sequence, which is, in principal, sufficient to 




pick out a single target site even in a complex genome. However, in practical, the 
design and construction of zinc finger nucleases was not that easy. Simply fusing of 
the fingers that recognize target sequence doesn’t always work. Several 
combinations need to be tested on yeast system and the best can be selected (Carroll 
et al., 2006; Mani et al., 2005). Accumulative evidences showed that zinc fingers not 
only bind to three nucleobases, but also interact with one more nucleobase, which is 
opposite to the nucleobase that is adjacent to the 3’- end of the three nucleobases 
recognized by the zinc finger(Isalan et al., 1997; Isalan et al., 1998). This has been 
the cause of incompatible zinc fingers in ZFNs. In 2011, Sander and his colleagues 
reported a method called context-dependent assembly (CoDA) to solve this problem 
(Sander et al., 2011). It was realized that design and construction of ZFNs can be 
much easier by referring to previously proven zinc finger arrays. Thanks to the 
development of ZFN community, there has been enough data to be referred to. The 
sequence of two zinc fingers is called a ‘context’. If a context is already proven by a 
published ZFN, then the context can be used to combine with other contexts to 
construct new ZFNs. For example, if two ZFN arrays, one consisting zinc fingers 
A-B-C and the other consisting of zinc fingers D-A-E, was reported, then the 
contexts ‘A-B’ and ‘D-A’ are considered solid. A new array consisting of zinc fingers 
D-A-B can be constructed without testing the efficiency, because contexts A-B and 




1.1.3. Transcription activator-like effectors nucleases 
Transcription activator-like effectors (TALEs) are DNA binding proteins found in 
plant bacteria Xanthomonas. The bacteria utilize a Hrp-type III secretion system to 
inject TALEs into the cytoplasm of plant cell. TALEs will be transport into plant 
cell’s nucleus due to the nuclear localization signal near its C-terminus. They 
naturally bind to promoter regions of plant genes after localize to nucleus, just like 
transcriptional activators. The cellular environment will be altered to weaken the 
defense of plant cell, fit for bacteria proliferation, spreading and etc. (Sugio et al., 
2007; Yang et al., 2006). The reason that TALEs can target various plant gene 
promoters is that it can alter its modular repeats to target different sequences. 
 
Figure 1.2. Cartoon of a native TALE. Adapted from (Boch et al., 2009b  ).
The TALE has a big family. Typical TALEs have a 283-290 aa N-terminus, a 
274-297 aa C-terminus and the DNA binding domain of varying length in the middle 
(Boch and Bonas, 2010) (Fig. 1.2). It has been found out that the end of N-terminus 
is responsible for translocation by Hrp-type III secretion system (Szurek et al., 
2002a). It has also been found out that the nuclear localization signal (NLS) locates 
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near the C-terminus (Yang and Gabriel, 1995), while the transcription activation 
domain resides at the end of C-terminus (Zhu et al., 1998).  
The domain consisting tandem repeats in the middle of the TALEs are 
responsible for DNA recognizing (Herbers et al., 1992), turning out to be a novel 
type of modular DNA binding domain. It was found out that each one of the repeats 
is responsible for one base pair recognition, while the recognition sequence of 
TALEs always starts with a T, probably determined by the residues to the right of 
their DNA binding domain (Boch et al., 2009b; Moscou and Bogdanove, 2009). The 
tandem repeats, except for the last one, consist of various numbers of amino acids 
ranging from 30 to 42 aa, while the predominant majority of them consist of 34 
amino acids (Boch and Bonas, 2010). The last repeat in the DNA binding domain 
only consists of 19 or 20 aa, seemingly a truncated half repeat. Within 34 aa repeats, 
the repeat units from across different family members are highly conserved, except 




Figure 1.3. RVD types in Xanthomonas. Adapted from (Boch and Bonas, 2010). 
10 
 




 amino acids are 
hypervariable and together determine the specificity of the DNA recognition (Fig. 
1.2) (Boch et al., 2009a; Moscou and Bogdanove, 2009). This pair of amino acids is 
called repeat variable di-residue (RVD). There are various compositions of RVDs 
found in the TALE family (Fig. 1.3). These RVDs have been allocated target 
nucleotides based on the target sequences of the TALEs where the RVDs were found. 
However, because of the abundance of RVDs varies, the deduction of RVD to 
nucleotide relationship is not always reliable because of sample size. Only the 
predominantly abundant RVDs have proven themselves in the tests of 
nucleotide-binding specificity (Streubel et al., 2012). There are 4 abundant RVDs 
that have experimentally proven specificity for binding DNA: NI, corresponding to 
A; NG, corresponding to T; NN, corresponding to both G and A, with a slight 
preference towards G; HD, corresponding to C (Boch et al., 2009a; Moscou and 
Bogdanove, 2009). NS is also an experimentally proven RVD, but it doesn’t have a 
preference for recognizing nucleotides. Other abundant RVDs N* (losing the 13
th
 aa) 
and HG only have the predicted binding preference but haven’t been experimentally 
proven. Taken together, tandem repeats in the DNA binding domain of TALEs have a 
range of RVDs that will cover binding specificity for all 4 types of DNA nucleotides. 
Since the repeats of TALE binding domain are highly modular and the RVD to 
DNA code has been deciphered, TALEs can also be engineered to be TALE 
nucleases (TALENs) similar to the way that ZFNs are engineered (Fig. 1.4). The 
early reported TALENs comprise full length of TALE’s N- and C-terminus except 
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for the transcription activation domain for activating plant gene’s transcription, 
which is not necessary for the DNA binding property of TALE (Cermak et al., 2010). 
A FokI nuclease is used to replace the activation domain of TALE to form a TALEN, 
a pair of which will reciprocally pair at the C-terminus to form a FokI dimer upon 
binding to target DNA sequences. The spacer sequence between the two TALEN 
target sequences will be cut by the FokI dimier. The N-terminus serves as a linker 
between the DNA binding domain and the FokI nuclease. This linker is very long as 
compared to ZFN’s, leading to a longer spacer between two TALEN targeting 
sequence (Cermak et al., 2010). Later on, researchers have tested truncated versions 
of TALEs in the constructions of TALENs, deleting various lengths of the 
N-terminus and C-terminus in TALEs, since most of the amino acids there are not 
relevant to their DNA binding ability. It has been shown that TALENs with truncated 
versions of N-terminus consisting of the first 153 or 147 residues to the right of the 
DNA binding domain gave rise to targeting efficiencies that were not significantly 
different from the full-length ones (Miller et al., 2011). On the other hand, it has 
been shown that TALENs with truncated versions of C-terminus consisting of 17, 28, 
47 or 63 residues to the left of the DNA binding domain possessed similar targeting 
Figure 1.4. Cartoon of a TALEN dimer bound to DNA. 
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efficiencies to the full-length ones when the spacer was 15 bp (Zhang et al., 2011). 
After these studies, new designer-TALENs are 200 residues shorter than the 
full-length ones, which at least reduce 20% of the size, making designer TALENs 
more compact. 
Comparing to ZFN, each repeat of a TALEN in the DNA binding domain Has a 
one-to-one correlation to the nucleotides in the target binding sequence, thus 
TALENs are easier to design. Moreover, newly synthesized TALENs have a very 
high successful rate. In a report of high-throughput synthesis of TALENs, out of 96 
pairs of TALENs targeting 96 different genes, 84 of them showed efficient 
NHEJ-mediated mutagenesis at their intended target sites, which is 88% (Reyon et 
al., 2012). However, ZFNs have a more compact protein structure, making ZFNs 
usually only one-third to half of TALENs in regard of the length of coding sequences 
or amino acids. 
1.1.4. RNA-guided engineered nucleases 
CRISPR/Cas system is found among the adaptive immune systems in bacteria. In 
bacteria, it recognizes and stores foreign DNA sequences in between clustered 
regularly interspaced short palindromic repeats and transcribes them as CRISPR 
RNAs (crRNAs) to lead the CRISPR associated nucleases (Cas) to target the foreign 
DNA upon next infection of the same pathogen (Barrangou et al., 2007; Brouns et al., 
2008; Horvath and Barrangou, 2010). Researchers have utilized this mechanism and 
13 
 
make Cas a new kind of programmable nuclease (Jinek et al., 2012b). They also 
invented a hybrid of the two essential non-coding RNAs in the CRISPR/Cas system 
(Fig. 1.5). Specifically, minimal regions of crRNA and trans-activating crRNA 
(tracrRNA) were fused by a linker loop, making a single chimeric guide RNA 
(gRNA) that is able to guide the Cas. Engineered gRNA can be used to direct Cas to 
any target sequences that end with a protospacer adjacent motif (PAM), which is 
NGG for Streptococcus pyogenes. The DNA recognition in this system is RNA to 
DNA, different from the previous protein to DNA recognitions. This property makes 
the designing and engineering of gRNA much easier than engineering ZFN and 
TALEN.  
It has been reported that this system has a very high efficiency, enabling 
multiplex genome engineering in the same time (Cong et al., 2013), but may also 
possess a higher off-targeting probability (Fu et al., 2013; Hsu et al., 2013). The 
Figure 1.5. Cartoon of a Cas9 programmed by single chimeric RNA. 
Adapted from (Jinek et al., 2012a). 
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higher off-targeting rate is partially due to the fact that, within the target sequence, 
only a seed sequence of 10 to 12 bp from PAM strongly restricts the specificity of 
CRISPR/Cas cleavage. Obviously, 10 to 12 bp is not enough for achieving 
satisfactory specificity in most vertebrate genomes. The off-targeting rate can be 
reduced by using two CRISPR/Cas nickase to reciprocally target two nearby 
sequences like ZFNs and TALENs, increasing the seed sequence to 20 to 24 bp 
(Scott et al., 2013). However, the two target site cannot be separated for too far away 
for the binding affinity between the two strands of DNA increases with the increase 
of nucleotides between the two nicks, making the design of gRNA to match PAM 
harder.   
1.1.5. Genome engineering approaches 
Empowered by programmable endonucleases, many new ways of manipulation 
of the genome has been developed, making genome engineering much more versatile. 
These ways of manipulation of genome can be generally allocated to two categories 
by the DNA repair mechanism that they utilize. One is non-homologous 
recombination end joining (NHEJ), the other is homologous dependent repairing 
(HDR). 
NHEJ based genome engineering includes gene disruption, large fragment 
deletion and large fragment inversion. NHEJ joins broken DNA ends in an imperfect 
way, which will leave errors ranging from several to a few bps (Moore and Haber, 
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1996). If a programmable endonucleases-generated error is created at the beginning 
of the target gene’s open reading frame, there will be a chance that the open reading 
frame is disrupted by a frame-shift mutation. Given that genetic codons consist of 
nucleotides in triplets, the chance of gene disruption should be 2 out of 3 times. 
Other than inducing frame-shift mutation, programmable endonucleases can also be 
used to delete large fragment of several to dozens kb from genome, by creating two 
DSBs flanking the large fragment that is to be deleted (Wang et al., 2013; Xiao et al., 
2013). Another outcome of this creation of two DSBs is large-fragment inversion. 
Instead of joining the two ends of cleaved genome, there is a chance that the 
fragment is ligated back to the genome but in an inverted manner (Xiao et al., 2013).  
HDR based genome engineering can be categorized according to the kind of 
donor DNA template used: double-stranded DNA (dsDNA) or single-stranded DNA 
(ssDNA). Similar to traditional gene targeting, dsDNA donor triggers homologous 
recombination and swap genetic information into or out of the target site. However, 
for the programmable endonucleases-aided genome engineering, donors containing 
around 3 to 5 kb of homology are able to produce a much higher efficiency of gene 
targeting (Yang et al., 2014). This method is of most fidelity in genome engineering. 
Conditional knockout/in can be achieved by adding loxP sites to both sides of the 
targeting cassette in the donor. Short ssDNA is also reported to be able to direct 
HDR of the target site of programmable endonucleases (Bedell et al., 2012). Target 
sequence of dozens of bp can be manipulated using this method. An ssDNA with 60 
bp homology arm on each side of the cassette, which is also several dozens of bp 
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long, can induce HDR upon DSB. By this method, loxP site, tags and restriction 
enzyme sites can be introduced to the target site with a high fidelity. 
A newly emerged way of genome engineering utilizes microhomology-mediated 
end joining (MMEJ) to perform targeted knock-in into DSB site with the direction in 
control. Principally, 100 bp of homology sequence, with 50 bp homology sequence 
on each side, is enough to trigger the MMEJ pathway to repair the DSB in 
accordance to the 750 bp-cassette flanked by the 50 bp homology sequence (Orlando 
et al., 2010). The achieved integration efficiency is 10%, with half of the deletion 
sites inserted with the microhomology-cassette. In another report that uses TALENs 
and CRISPR instead of ZFN, only a microhomology of 5 to 25 bp in each side of the 
1600 bp-targeting cassette achieved a 10% knock-in efficiency, which was not 
including the incomplete inserts (Nakade et al., 2014). 
In conclusion, programmable endonucleases are powerful tools for modern life 
sciences and are rapidly expanding their application area. They are still continuing to 
grow and improve, enabling various ways of genome engineering and making great 




1.2.  Medaka germline development and germ plasm 
1.2.1. Medaka primordial germ cell specification and migration 
Germ cells are the only cell type to be able to transmit genetic information 
through generations. The germline development of animals starts from primordial 
germ cell (PGC) formation, which is a set of cells that are set aside early in the 
embryonic development. There are two types PGC formation modes: preformation 
and epigenesis (Extavour and Akam, 2003). For example, in drosophila, PGC 
specification is categorized as preformation (Fig. 1.6, left). Maternally synthesized 
germline determinant (blue) containing proteins and mRNAs is deposited to the 
posterior pole of the embryo and dictates the formation of PGCs (blue in red circles) 
in the posterior pole later. These germline determinants are called germ plasm. 
Generally, germ plasm distribution dictates PGC specification in animals using 
preformation mode. In mouse, PGC specification is categorized as epigenesis (Fig. 
1.6, right). There is no maternally deposited germ plasm observed in mouse. Instead, 
after the segregation of embryonic and extraembryonic tissues, a subpopulation from 
the pluripotent epiblast cells expresses some genes that are competent for germline 
commitment (striped circles) and are able to differentiate into PGCs (red circles) 




    
Figure 1.6. PGC specification of drosophila and mouse. Adopted from (Extavour 
and Akam, 2003). 
Medaka germline specification is categorized as preformation. Therefore, there 
is maternally deposited germ plasm in medaka embryos. Cells who inherit germ 
plasm in the animal pole of early blastula (stage 10) become PGCs (Fig. 1.7, top left) 
(Kinoshita et al., 2009). These PGCs will remain there until gastrulation starts, 
which means the beginning of PGC migration. PGC migration is part of medaka 
germline development. PGCs will migrate into the gonadal primordium and develop 
with somatic gonadal cells to form gonad. The PGC migration is majorly controlled 
by a simple ligand-receptor interaction (Kurokawa et al., 2006). The ligand is a 
chemokine expressed in the lateral plate mesoderm, called SDF-1a. The receptor is 
CXCR4 from PGC side. During PGC migration, the SDF-1a’s lateral plate 
mesoderm expression is restricted to the region with gonadal somatic precursors. 
The SDF-1a is the guiding signal sent from these precursors to tell where the PGCs 
should migrate towards. During gastrulation, PGCs actively migrate from the animal 
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pole to the dorsal half of the marginal zone within hours, where SDF-1a expression 
is concentrated (Fig. 1.7, stage 15). During the late gastrula stage to early neurula 
stage (Fig. 1.7, stage 16-17), the lateral plate mesoderm moves medially, driving 
PGCs toward the embryonic body by convergent extension. Then, PGCs align along 
the SDF-1a-expressing lateral plate mesoderm. The SDF-1a expression domain 
becomes restricted to the posterior part of the lateral plate mesoderm as 
somitogenesis proceeds (Fig. 1.7, stages 19-26), directing the PGCs to the posterior 





Figure 1.7. Medaka PGC migration (stages 10-26). Adopted from (Kinoshita et al., 
2009). 




 somites in the lateral plate mesoderm 
at around stage 26. This is the place where gonadal somatic precursors reside 
((Nakamura et al., 2006)). They are spatially organized into two populations, which 
occupy the anteromedial and posterolateral parts of this region. Then the anterior 
population of gonadal somatic cells moves towards the middle of the body axis onto 
the dorsal side of the hindgut, which is the prospective gonadal region (Fig. 1.8, 
stage 27-30). In the same time, the posterior population goes to the lateral sides of 
the hindgut in the following of anterior population. After this, the two populations 
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express distinct marker genes: the anterior one expresses sox9b, and the posterior 
one expresses ftz-f1. In the same time, the PGCs also reach the region of posterior 
population and go on to the anterior population region, which is on the dorsal side of 
hindgut. The anterior sox9b-expressing population then envelops the PGCs during 
stages 31-33 (Fig. 1.8, top right). Now the gonadal primordium formation completes, 
and will separate into two lobes during stage 33 to 35 (Fig. 1.8, bottom). Upon this 





Figure 1.8. Medaka PGC migration (stages 26-35). Adopted from (Kinoshita et al., 
2009). 
1.2.2. Medaka dead end and germ plasm 
Gene dead end (dnd) was first identified as a maternal gene that encodes RNA 
and protein as components of germ plasm in zebrafish (Weidinger et al., 2003). It 
was found that ablation of dnd induces sterility in zebrafish (Weidinger et al., 2003) 
and high frequency of testicular  germ-cell tumors in mouse (Youngren et al., 2005). 
Further investigation into the mechanism of the phenomena showed that Dnd 
protects mRNAs from degradation by blocking the microRNA binding sites at the 
3’-UTR of the target genes (Fig. 1.9) (Ketting, 2007). By dnd protein: messenger 
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RNAs of Germ plasm genes nanos1 and tdrd7 were protected from miR-430 
mediated degradation in zebrafish PGCs; Oncogene miR-221 were prevented from 
degrading mRNA of p27 in human germline cells; and miR372 were prevented from 
degrading mRNA of LATS2 in human Ter1 cells (Kedde et al., 2007).  
 
Figure 1.9. Dnd prevents microRNA mediated mRNA degradation. Adapted 






Medaka dnd is a maternal germline-specific gene, its expression is restricted in 
the PGCs and gonads (Liu et al., 2009). Observing the subcellular expression of Dnd 
by using Dnd-mCherry fusion protein showed that Dnd protein form granules in 
cytoplasm, co-localizing with Vasa. This result indicates that Dnd is a component of 
germ plasm, too. Amino acid alignment between species shows that the RNA 
recognition motif (RRM) is highly conserved across species, while the whole protein 





Figure 1.10. Dnd alignment and structure. Adapted from (Liu et al., 2009). 
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1.3.  Objectives of the thesis 
The main aim of this research project was to:  
(1) Explore and validate the procedures and parameters for TALEN-mediated 
genome editing on the chromosomal locus dnd in medaka embryos via mRNA 
injection;  





CHAPTER 2. MATERIALS AND METHODS 
2.1.  Materials 
2.1.1. Fish 
Medaka fish (Oryzias Latipes) are maintained in fresh water with a temperature 
range of 24-30 °C and a light/dark cycle of 14/10 hr. Strains HdrR, HdrR-II, Orange 
and AF (Auto-fluorescence free) were used for microinjection, crossing, in situ 
hybridization and photographing. All the experimental procedures are followed the 
Guidelines on the Care and Use of Animals for Scientific Purposes of the National 
Advisory Committee for Laboratory Animal Research in Singapore. Embryos are 
staged according to (Iwamatsu, 2004). 
2.2.  Reagents 
2.2.1.  Reagent list 
The complete list of commercialized reagents, listed in a sequence according to 
where in the method section they are first mentioned, is detailed in Appendice I. 
2.2.2. Reagent setups 
(1) Tris-EDTA (TE buffer): 10 mM pH 8.0 Tris and 1 mM EDTA. 
(2) TAE: 40 mM Tris-HCl, pH 8.0, 20 mM acetic acid and 1 mM EDTA. 
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(3) TBE: 89mM Tris-HCl, pH 8.0, 89 mM Boric acid and 2 mM EDTA. 
(4) TNES-6U: 10mM Tris-HCl, pH 7.5; 125mM NaCl; 10mM EDTA; 1% SDS; 6M 
Urea. 
(5) Direct PCR lysis buffer: 50 mM Tris-HC1 (pH 8.5), 1 mM EDTA, 0.5% SDS, 
200 µg/ml proteinase K. 
(6) 10 mg/ml Proteinase K: 0.1 g Proteinase was dissolved in 10 ml 60% Glycerol 
and store at -25 °C. 
(7) Preparation of Torula Yeast RNA for hybridization solution: One gram of torula 
RNA powder was added to a 50 ml Falcon tube. Ten ml of phenol and 15 ml of TE 
were added to each tube. The tube was mixed under very hard vortex until powder 
dissolves. After all the torula RNA powder in tubes was dissolved, the tubes were 
centrifuged in table top centrifuge for 10 min. Top phase was removed to a clean 50 
ml Falcon tube followed by one phenol/chloroform extraction and one chloroform 
extraction. One ml of 3M NaOAc and 30 ml of ethanol were added to the 
supernatent. The mixture was let stand for 5 min and spin 20 min at full speed to 
pellet the RNA. The supernatant was decanted and an RNAse-free 80% ethanol 
rinse was performed to remove salts. The tube was centrifuged for 10 min，the 
supernatant was decanted and the pellet was air-dried. Then the pellet was dissolved 
in 15 ml RNase-free water. The concentration was measured on the spectrometer. 
The volume was increased to reach a 20 mg/ml final concentration. The torula RNA 
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was then aliquot into 15 ml falcon tubes and store at –20 °C. (Jing, 2012). 
(8) Hybridization buffer: Hybridization buffer used for whole mount in situ 
hybridization contains 50% formamide, 5xSSC (pH 7.0), 500 μg/ml torula yeast 
RNA, 50 μg/ml heparin, 0.1% Tween 20, and 9mM citric acid for adjusting the pH to 
6.0-6.5. 
(9) CCMB80: 10 mM KOAc pH 7.0 (10 ml of a 1M stock/L), 80 mM CaCl2.2H2O 
(11.8 g/L), 20 mM MnCl2.4H2O (4.0 g/L), 10 mM MgCl2.6H2O (2.0 g/L), 10% 
glycerol (100 ml/L), adjust pH DOWN to 6.4 with 0.1N HCl if necessary,  
(10) Embryo rearing medium: To make 1L: NaCl 1.0 g, KCl 0.03 g, CaCl2.2H2O 
0.04 g, MgSO4.7H2O: 0.163 g, Methylene blue 0.01 % 10 ml, distilled Water to 1 L. 
(11) Yamamoto’s Ringer’s solution: 0.75%, NaCl 0.02%, KCl 0.02%, CaCl2 0.002%, 
NaHCO3 (Adjust to pH 7.3 with NaHCO3). 
2.2.3. Equipments 
Electrophoresis systems, including horizontal system and the vertical system, 
were from Bio-Rad. 
Thermocyclers were Mastercycler® pro from Eppendorf. 
MZFIII stereomicroscope from Leica was used to observe the embryos and fish. 




Centrifuges for 1.5 or 2 ml tubes were from Eppendorf and Thermo Scientific. 
Centrifuges for 15 or 50 ml tubes were from Eppendorf and Sigma. 
2.2.4. Plasmids 
pTNdnd1 and pTNdnd2 are the TALEN vectors constructed by using method 
and plasmid arrays published as (Cermak et al., 2011). pCS2:gfp:nos-3’-UTR was 
constructed by Prof. Li Mingyou, my senior and an alumni of our lab. 
pCS2:dnd:gfp:dnd-3’-UTR was constructed by changing the mCherry of 
pCS2:dnd:mCherry:dnd-3’-UTR to gfp.  pCS2:dnd:mCherry:dnd-3’-UTR was also 

























2.2.  Methods 
2.2.1. Genomic DNA extraction 
Genomic DNAs of organs, tissues or embryos were extracted by lysis buffer 
TNES-6U. For each 25 mg of sample, 180 μl of lysis buffer plus 20 μl of 10 mg/ml 
proteinase K were used. The samples were homogenized in the lysis buffer using a 
plastic pestle and incubated in 55℃ for 3 hr or overnight. During the incubation, the 
tubes should be subjected to vortexes every half an hour. After digestion, the mixture 
was subjected to two phenol-chloroform extractions to remove the non-nucleic acid 
components and two chloroform extractions to remove the residue phenol. 
Isopropanol equals to 0.7 volume of the extracted solution and 0.1 volume of 5M 
NaCl were then added and mixed. The mixture was let stand for 15 min in room 
temperature and centrifuged for 15 min under 18000 rcf. The supernatant was then 
decanted and 1 ml of 70% ethanol was used to wash the pellet. The tube was 
centrifuged again to decant the 70% ethanol. This wash step was repeated once. The 
pellet was let dry after removing as much 70% ethanol as possible. Appropriate 
amount of TE buffer or water was used to resuspend the genomic DNA. The quality 
and quantity of the genomic DNA were checked and determined by electrophoresis 
with DNA ladder. 
2.2.2. Chemically prepared competent cell 
Hanahan & Inoue’s methods of preparing chemically prepared competent cells 
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were adopted and combined (Hanahan et al., 1991; Inoue et al., 1990). Inoculation of 
exponentially growing E.coli: Streak stock bacteria culture on an antibiotic-free LB 
plate and pick up single colonies to inoculate at 37℃ overnight (16hrs). Pick single 
colony to inoculate in 2 to 5ml LB at 37℃ overnight. In the next morning, inoculate 
the overnight culture in a 1 to 100 ratio to a new flask of LB. The culture volume 
should not exceed one fifth of the max volume. This inoculation should be 
performed in low temperature, such as 18℃. The low temperature is critical to the 
transformation efficiency. The inoculation duration depends on the temperature used. 
Normally for 18 ℃, 40 hr is enough, the time increase with the decrease of 
temperature. The OD of the inoculation should be checked every hour during the last 
5 hours of inoculation. An OD between 0.6 is acceptable. Re-suspension of the 
bacteria using transformation buffer CCMB80: Centrifuge the culture at 2000 g and 
4C for 10mins. (Before this step, if the bacteria haven’t been put on ice more than 
20mins, wait until then.) Discard the supernatant and re-suspend the bacteria using 
CCMB80. For every 50ml culture, use 16ml CCMB80. Keep it on ice for 20mins. 
Centrifuge the culture at 2000 g and 4C for 10mins. Discard the supernatant and 
re-suspend the bacteria using CCMB80. For every 50ml culture, use 2~4ml 
CCMB80 (depending on O.D., 0.3 is to 2ml as 0.6 is to 4ml). Keep it on ice for 
20mins. Aliquot the suspension to 50 or 100ul aliquots and keep them in -80C fridge. 
2.2.3. TA cloning 
PCR products were gel-extracted using gel-extraction kits and subjected to TA 
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cloning with a 3 to 1 insert-to-backbone-ratio, using TA cloning kit from Thermo or 
Promega. After 15 min to 1 hr of incubation, 2.5 µl the ligation product was 
transformed into 100 µl competent cells. 
2.2.4. Plasmid DNA preparation 
Mini-prep of plasmid DNA was prepared as following description. E. coli 
transformed with plasmid DNA was inoculated overnight in 37℃ shaker with 240 
rpm of shaking. The bacteria were pelleted by 5 min of 6000 rcf centrifugation. After 
decanting the supernatant, plasmid extraction buffer I was used to resuspend the 
bacteria. Plasmid extraction buffer II was used to lyse the bacteria for 1 to 3 mins. 
Plasmid extraction buffer III was then added to neutralize the mixture and precipitate 
cell debris, proteins and genomic DNAs. After mixing, put the tubes on ice for 5 
mins and centrifuge them for 15 min under 18000 rcf. Transfer the supernatant to a 
new 1.5 ml tube and add isopropanol equals to 0.7 volume of the solution were then 
added and mixed. The mixture was let stand for 15 min in room temperature and 
centrifuged for 15 min under 18000 rcf. The supernatant was then decanted and 1 ml 
of 70% ethanol was used to wash the pellet. The tube was centrifuged again to 
decant the 70% ethanol. This wash step was repeated once. The pellet was let dry 
after removing as much 70% ethanol as possible. Appropriate amount of TE buffer 
or water was used to resuspend the plasmid DNA. The quality and quantity of the 
plasmid DNA were checked and determined by electrophoresis with DNA ladder. 
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Mini- or midi-prep were also prepared using kits from Qiagen as described in 
the kits’ manuals. 
2.2.5. Restriction enzyme digestion 
Some general guidelines for restriction enzyme digestion are as follows. For one 
hour digestion, amounts of used restriction enzyme were 5 units for every µg of 
Plasmid DNA to be digested. For overnight digestion, amounts of used restriction 
enzyme were 1.25 units for every µg of Plasmid DNA to be digested. Compatibility 
of double digestion should be checked in the enzyme’s company’s webpage. If the 
compatibility is not satisfactory or non-existent, double digestion can be performed 
instead. The DNA should be analyzed on a gel to confirm the complete digestion 
after incubation with first enzyme. The DNA should then be precipitated and 
resuspend with the second enzyme’s reaction mix. For the second enzyme, because 
DNA is linear, only 1 unit is needed for 1 hr digestion, or 0.25 unit for overnight 
digestion. The incubation temperature of digestion should follow the manual of the 
specific enzyme. 
2.2.6. Whole RNA extraction 
Tissues or organs of interest up to 100 mg were submerged into 100 μl of trizol 
and homogenized. Additional trizol of 900 μl was added and the tube was let stand 
on ice for 5 mins. 200 μl of chloroform was then added to the tube, which was 
shaken vigorously for 15 seconds. The mixture was centrifuged for 15 min under 
36 
 
15000 rcf to separate the organic and aqueous phase. The upper aqueous phase was 
transferred to a new tube and extracted again with chloroform in order to remove 
residue phenol. Again transfer the upper aqueous phase to a new tube and add 500 μl 
of isopropanol, mix and stand for 10 min. Centrifuge the mixture for 10 min under 
12000 rcf, decant the supernatant and wash the pellet with 1 ml of 75 % ethanol. 
Centrifuge the tube again for 5 min under 12000 rcf and discard the supernatant. 
After the pellet was air-dried, resuspend it with DEPC-treated water and mix it by 
passing the solution up and down several times through a pipette tip. Heat the 
solution on a 55℃ heat block for 10 min. The RNA is ready for downstream 
applications. 
2.2.7. Synthesis of first strand cDNA 
First strand cDNA was synthesized by using Maxima First Strand cDNA 
Synthesis Kit for RT-qPCR from Thermo Scientific. Briefly, 0.1 to 1 µg total RNA 
was mixed with 4 µL of 5X reaction mix, 2 µL maxima enzyme mix and water to 20 
µL by passing the solution up and down through pipette tip. The reaction was 
performed on a thermo-cycler with the program: 25℃ for 10 min, 50℃ for 15 min 
and 85℃ for 5 min. if the GC content and the secondary structure of RNAs are high, 
increase the second temperature to 65℃. 
2.2.8. Microinjection 
One- or two-cell stage microinjection was performed as follows. To obtain 
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one-cell stage embryos, female and male fish were separated the day before injection. 
In the morning on the injection day, the male and female fish were put together and 
allowed for mating for 15 min before the embryos were collected. The collected 
one-cell stage embryos were dissociated by gently twisted between two dissecting 
needles and kept on ice. While waiting for the mating, centrifuge the to-be-injected 
solutions for 5 min under 15000 rcf. To load the centrifuged solutions to the 
microinjection needle: put some mineral oil on a piece of freshly opened parafilm; 
put 2 to 4 μl to-be-injected solution on the mineral oil; heat the needle briefly on an 
alcohol lamp and immediately placing the back of the needle on the solution; let the 
solution and the oil flow into the needle due to contracting of the heated air inside 
the needle. Afterwards, insert the loaded needle into the Leica micromanipulator and 
break the tip of the needle under microscope carefully. During the centrifugation, 
pour a 1.5% Ringer’s-TAE agarose gel into a 10 cm petri dish and put the 
microinjection mold on the gel. After obtaining dissociated one-cell stage embryos 
put them into the lanes of the gel and align their cells to the top right direction. In 
vitro transcribed mRNAs were then injected into one-cell stage embryos with 




2.2.9. Polymerase chain reaction (PCR) 
PCR for the purpose of screening using genomic DNA or cDNA as templates 
was performed by using Taq based polymerases, such as KAPA 2G, Takara’s Ex-Taq 
and Thermo’s DreamTaq. For each one of the thermocylcler programs, different 
temperatures and durations were used as the manuals suggest. Generally, a program 
is set as follows:  1 to 3 min of 95℃ denaturation; 25 to 35 cycles of 15 to 30 sec of 
95℃ denaturation, 15 to 30 sec of 50 to 60 ℃ annealing and 1 to 1 min of 72℃ 
amplification; 5 min of 72℃ final elongation. 
PCR for cloning was performed by using Pfu or Phusion polymerases for the 
low error rate of amplification. The thermocycler programs are similar to the 
previous one but the elongation needs more time because of the property of the 
enzymes. Moreover, since cloning primers are normally longer, the annealing 
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temperatures often go higher than 68℃, which needs to be coupled with another two 
cycle program. Specifically, it is: 1 to 3 min of 98℃ denaturation; 20 to 30 cycles of 
15 sec 98℃ denaturation and 30 sec to several min of 68 to 73℃ 
annealing/amplification; 72℃ final elongation. 
2.2.10. Direct PCR from lysed embryos or caudal fin clips 
For screening of progeny fish of mutant families, direct PCR was used for 
convenience, due to the large amount of samples. It is a very simple and efficient 
method adopted from a cold spring harbor protocol (Goldenberger et al., 1995). 
Briefly, small amount of samples (one embryo or a little piece of caudal fin clip in 
this case) were lysed by 50 µl of Direct PCR lysis buffer for 2 hr. After briefly mix 
the lysate by gentle vortexing, they are ready for PCR. An appropriate amount of 
Tween 20 need to be added into the PCR system, depending on the amount of SDS 
introduced into the system by the sample. The correlations between Tween 20 and 
SDS are listed below (final concentration in PCR system): 2% Tween 20 for 0.05% 
SDS; 5% Tween 20 for 0.2% SDS. 
2.2.11. Agarose gel electrophoresis of nucleic acid samples 
0.8 to 1.5% agarose gel in 1xTAE was casted depending on the size nucleic acid 
samples that are to separate. The gels were run under 70V for 30 to 45 min also 
depending on the size of the sample to be analyzed. 
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2.2.12. Poly-acrylamide gel electrophoresis (PAGE) of PCR products 
10% TBE-PAGE gel was used to reveal the heteroduplex PCR products of 
mutant alleles. They were casted using 10% AB (29:1), 0.005V 10% APS and 
0.001V TEMED in 1xTBE. The electrophoresis was performed in 1xTBE under 
100V for 2 hr. Afterwards, the gels were stained using 3xGelred in 1xTBE for 10min 
prior being photographed using gel documentation system. 
2.2.13. Detecting disrupted alleles of dnd in PCR products using capillary 
electrophoresis  
To prepare for capillary electrophoresis, 0.5 µl of PCR product, 0.5 µl of 
Genescan-500-ROX marker and 9 µl of HiDi-formamide were mixed together and 
subjected to ABI3130 or ABI3730 genetic analyzers. The results were analyzed in 
the Genemapper software. 
2.2.14. Sequencing of DNA samples using BigDye terminator 
Plasmid DNA or PCR products were used as the templates of BigDye terminator 
sequencing, using 100 to 200 ng or 10 to 25 ng of them, respectively. A 1/8 BigDye 
reaction was performed in 10 µl system for sequencing. Thermocycler program was 
set as: 1min 96℃ denaturation; 25 cycles of 10 sec 96℃ denaturation, 5 sec 50 to 55℃ 
annealing; 2 min 60℃ elongation. The 10µl sequencing reaction product was 
precipitated by adding 1 µl 3M NaAc, 2.5 µl EDTA and 3V of ethanol. The pellete 
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was washed for once by 70% ethanol and let dry. The dried pellete was resuspended 
by HiDi-formamide for sequencing on ABI3130 or ABI3730 genetic analyzer.  
2.2.15. In vitro synthesis of RNA 
Messenger and probe RNA was synthesized using mMESSAGE mMACHINE 
transcription kits. To prepare template for RNA synthesis, 10 μg plasmid DNA was 
linearized using restriction enzyme. The linearization was confirmed by agarose 
electrophoresis. The digestion was cleaned up by phenol-chloroform extraction, 
precipitated by 2.5 volumes ethanol and 0.1 volume 4M ammonium sulphate (from 
the kit), washed by 75% ethanol and resuspended by 30 μl of nuclease-free water. 
After the concentration of linearized plasmid DNA was determined, the mRNA was 
synthesized according the protocol from the kit manual. For microinjection, the 
synthesized RNA was resuspended with nuclease-free water or DEPC-treated 
Ringer’s solution with 0.1% phenol red. For in situ hybridization probes, the 
synthesized RNA was resuspended with 50% formamide in DEPC-treated water. 
2.2.16. Whole-mount In situ hybridization 
2.2.16.1. Preparation of embryos 
The embryos were fixed at 4℃ over one to two nights and washed in PBS/PBT 
twice for 5 min each time. Then the embryos were dechorionated and equilibrated in 
methanol for 5 mins. The methanol was changed and the embryos were stored in -20℃ 
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overnight, embryos can be stored this way for several months. The embryos should 
be kept in -20°C for at least 2 hours before proceeding to next step. The fixed 
embryos were rehydrated by soaking for 5 min each in: 75% methanol + 25% PBT; 
50% methanol + 50% PBT; 25% methanol + 75% PBT. Young embryos (before 1 
somite) seem to be rather fragile during rehydration. Then the embryos were washed 
for 5 min for 4 times in 100% PBT. The embryos were incubated in proteinase K (10 
μg/ml PBT) at room temperature. The incubation time depends on the fixation and 
may vary for different batches of the proteinase K. The incubation time ideally 
should be titrated. In this thesis, 10 min, 15 min, 20 min, 25 min and 30 min were 
used for stage 21, 2-dpf, 3-dpf, 4-dpf and 5-dpf embryos, respectively. Wash with 
PBT twice, each for 5 mins. The embryos were refixed in 4% paraformaldehyde in 
PBS for 20 min at room temperature and washed 5 times, each for 5 min with PBT. 
2.2.16.2. Hybridyzation 
Embryos were pre-hybridized in hybridization buffer for at least 1 hour 
(preferably for 4-5 hours) at 70°C in 50% formamide. The pre-hybridization buffer 
was discarded and hybridization buffer containing probe was added. Fifty ng of 
digoxigenin-labeled probe in 200 μl hybridization solution was used to hybridize the 
embryos. The tube containing the embryos and hybridization buffer was incubated 
overnight at 70°C in a 1.5 ml microfuge tube in a water bath with gentle shaking. 
Probes are stable in hybridization buffer and can be reused several times. Washes 
were all done at the hybridization temperature with preheated solutions: 10 min 75% 
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hyb + 25% 2x SSC; 10 min 50% hyb + 50% 2x SSC; 10 min 25% hyb + 75% 2x 
SSC; 10 min 100% 2x SSC. Embryos were then washed for 30 min twice with 0.2x 
SSC at 70°C. Then the following washes were performed at room temperature: 5 
min 75% 0.2x SSC + 25% PBT; 5 min 50% 0.2x SSC + 50% PBT; 5 min 25% 0.2x 
SSC + 75% PBT; 5 min 100% PBT. 
2.2.16.3.  Detection 
The embryos from previous step were put into blocking buffer (2% goat serum, 
2mg/ml BSA in PBT) for at least one and a half hours (ideally 3 to 4 hours) at room 
temperature. After blocking, the embryos were put into blocking buffer containing 
anti-dig-AP (1:5000) overnight at 4°C with gentle shaking. The next day, the 
embryos were washed 6 times in PBT for 15 min at room temperature. Before two 
times of 5 min NTMT wash, a 5 min TBST wash was performed to avoid formation 
of magnesium phosphate precipitation. The washed embryos were stained in proper 
amount of diluted NBT/BCIP (200 μl stock solution in 10 ml NTMT) at room 
temperature or 4°C in dark. The staining was stopped by one quick wash and two 15 
min wash with stop solution when desired signal was reached. After stopping the 
development of staining, the embryos were fixed again with 4% PFA for 20 min and 
washed 3 times for 5 min each time to remove the residual PFA. The embryos were 
put into 3% methylcellulose for imaging. For long term storage, the embryos can be 
kept in 4% PFA in fridge. 
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2.2.17. Bioinformatic analysis 





CHAPTER 3: RESULTS 
3.1.  Gene editing of dnd by TALENs in medaka embryos 
The invention and utilization of programmable endonucleases has enabled 
efficient targeted genome editing in various organisms. In this thesis, the feasibility 
of transcription activator-like effector nucleases (TALENs) in generating gene-edited 
medaka fish via microinjecting TALEN mRNAs into 1-cell stage embryos was 
examined. Key parameters resulted from various dosages of TALEN mRNAs, such 
as survival rates, GE efficiencies in F0 embryos and adults and germ-line 
transmission rates, were analyzed. 
3.1.1. Experimental design for GE target locus and TALENs 
For a pair of TALENs to successfully induce GE, the most essential rule is to let 
the targeting sequence to be within the exon and be as close to the starting codon as 
possible. Therefore, with frame-shift mutations abolishing whatever amino acids 
encoded after the targeting sequence, the majority of the protein is altered. Gene dnd 
has a transcript of 1119 nt and encodes a protein of 372 amino acids. The most 
important domain of Dnd is the RNA recognition motif (RRM), which ranges from 
amino acid 53 to 125 and its coding sequence ranges from the 159
th
 base pair to the 
375
th. Because the role of RRM is critical for Dnd’s biological function as an 




A sequence spanning 49 base pairs at the beginning of dnd exon 3 was chosen as 
the target sequence of TALENs. This sequence ranges from the 127
th
 to the 175
th
 
base, so that the end of it has a 19-bp overlapping with the coding sequence of Dnd 
RRM. A frame-shift mutation created here abolishes 77% of the subsequent amino 
acids. Moreover, there may be frame-shift mutations that alter the overlapping 
sequence, part of RRM. These mutations can eliminate the possibility of gene 
function recovery by alternative splicing, when the functional motif itself is 
anticipated to be disrupted. 
Two vectors, namely pTN1dnd and pTN2dnd, were constructed to express two 
TALENs targeting the target site discussed above (Fig. 3.1). They are shown for 
coding nucleotide sequence and the encoded protein sequences in Appendice II. This 
target sequence is present only once in the medaka genome by a search using 
BLAST (http://www.ensembl.org/Oryzias_latipes/Info/Index). Two primers were 
designed for PCR genotyping (Fig. 3.1, bottom), which flank a 196-bp fragment 
spanning the target site (Fig. 3.3A). 
Overall, the target sequence of TALENs for dnd GE has been chosen to span 
from the beginning of dnd exon 3 to the beginning of RRM coding sequence, 




Figure 3.1. Medaka dnd’s protein & gene structure and its TALENs’ design. 
Shown is the map of pTN1dnd and pTN2dnd (top), the TALEN target site (middle; 
open triangle) and targeted alleles (bottom). The target site consists of two 
recognition sequences (underlined) flanking a spacer. Each of TALENs has 16 RVDs 
(black rectangles between N- and C-terminus) and – together with a T at the 5′ start – 
recognizes a total of 17 bp. The target site contains two 17-bp recognition sequences 
and a 15-bp spacer and is located within exon 3 of gene dnd. TALENs generate a 
double-strand DNA break (asterisk) within the target site to initiate DNA repair and 
thus yield GE alleles with subtle additions and deletions within or near the target site. 
Black arrowheads below the PCR product depict primers to amplify a 196-bp PCR 




3.1.2. Dose-dependent survival of TALEN-injected embryos 
Programmable endonucleases are expected to be lethal to cells to some extent, 
because of the off-targeting effect (Szczepek et al., 2007). Therefore, the toxicity of 
TALENs needs to be characterized before going to test the GE efficiency. The effects 
of various dosages on embryo survival were examined. The mRNA concentrations of 
TALENs injected initiated from 25 ng/μl for each of the TALENs. The following 
concentrations were all doubled up until an extreme one of 400 ng/μl killed 99.5% of 
injected embryos. For the lower concentrations, the survival rates at the hatching 
stage were 93%, 82%, 83% and 71% in embryos injected with 25, 50, 100 and 200 
ng/μl each of TALEN mRNAs, respectively (Table 1). DdH2O-injected embryos 
served as control and 97% of them survived until hatching stage. In general, the 
survival rates were negatively correlated with the injection concentrations. However, 

















Survivor, n (%) 
2)
 
Gastrula Hatching Fry 
0 30 30 (100) 30 (100) 29 (97) 
25 44 44 (100) 43 (98) 41 (93) 
50 66 62 (94) 56 (85) 54 (82) 
100 95 89 (94) 81 (85) 79 (83) 
200 111 103 (93) 91 (82) 79 (71) 
400 64 46 (72) 7 (11) 3 (0.5) 
1) 
The relationship between survival rate and various doses of TALEN mRNA was 
shown. TALEN mRNAs were injected at 25, 50, 100, 200 and 400 ng/µl. Water 
injection served as a negative control. 
2)
 Percentage values were derived by comparison to the number of embryos injected. 
 
3.1.3. Dose-dependent efficiency 
In order to produce a higher number of targeted embryos, not only a high 
survival rate but also a high GE efficiency is required. The dosage that provides the 
most surviving embryos doesn’t necessarily provide the most targeted surviving 
embryos. Therefore, the effects of different dosages on GE efficiency were tested on 
embryos. As expected, in PCR-heteroduplex mobility assay (PCR-HMA), no 
heteroduplex bands were revealed in PCR products of control embryos’ DNA other 
than the homoduplex band, showing a pure wild type (WT) allele composition of the 
DNA. On the other hand, both a bright homoduplex band and a varying number of 
additional dimmer heteroduplex bands were detected in PCR products of the 
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embryos injected with TALEN mRNAs, indicating the existence of various altered 
alleles and the WT allele in those embryos. Both the number and the intensity of 
heteroduplex bands increased with the dosage of injected TALEN mRNAs (Fig. 
3.2A). This trend was more evident after the enrichment of heteroduplex bands by 
another round of PCR-HMA assay using the extracted heteroduplex bands as 
template, for the rare mutant alleles was enriched (Fig. 3.2B). 
A densitometry-based semi-quantitative analysis using the Gel-Pro software was 
performed to examine the effect of TALEN mRNA dosage on the relative abundance 
of GE alleles. The relative intensity of heteroduplex bands was found to be 10.6, 
21.3 and 32.4% in embryos injected with 25, 50 and 100 ng/μl of TALEN mRNAs, 
respectively (Fig. 3.2C and Fig. 3.3). This revealed a correlation between GE 
efficiency and injected TALEN mRNA dosages. In parallel, the number of 
heteroduplex variants was found to be 2, 3, and 8 in embryos injected with 25, 50 
and 100 ng/μl of TALEN mRNAs, respectively (Fig. 3.2C and Fig. 3.4D), again 
revealing a correlation between the number of GE events and injected TALEN 
mRNA dosage. An exception to both correlations was seen in embryos injected with 
an extremely high TALEN mRNA dosage (≥200 ng/μl), where a decrease rather than 
an increase in intensity and number of heteroduplex bands was recorded (Fig. 3.2C). 
These results indicate that 100 ng/μl each of TALEN mRNAs is the most effective 
concentration in regards of getting most targeted alleles in developing embryos, 




Figure 3.2. Dose-dependent dnd GE efficiency. Embryos were injected at the 
1-cell stage with indicated doses of TALEN mRNAs. Genomic DNA was isolated 
from 25 pooled fry and PCR products were analyzed by PAGE. (A) GE alleles in 
heteroduplex  bands. (B) GE alleles in heteroduplex bands following enrichment by 
gel recovery and successive PCR (grsPCR). DNA size markers are shown to the 
right. Heteroduplex (Ht) bands migrate slower and are above homoduplex (Hm) 





Figure 3.3. Analysis of TALEN-mediated dnd GE. (A) Primers used for 
PCR-based genotyping. Forward and reverse primers are underlined. Spacer is in 
bold. (B) Quantification of heteroduplex PCR products. (C) Optic density (OD) of 
heteroduplex PCR products. (D) Numbers of heteroduplex PCR products. Hm, 
homoduplex; Ht, heteroduplex. 
 
3.1.4. GE efficiency in embryos and adults 
According to the above trials of concentrations, 100 ng/μl has been chosen as 
the working dosage for the following experiments. The GE efficiencies mentioned 
above are observed in the grouping of embryos, representing overall GE efficiencies 
for respective dosages. Subsequently, GE efficiency in individual embryos was 
characterized. Embryos injected with 100 ng/μl of TALEN mRNAs were 
individually sampled at 7 dpf for genotyping by PCR-HMA. There were 11 out of 20 
examined embryos showed obvious heteroduplex bands (Fig. 3.4A), demonstrating 
the generation of GE alleles-containing embryos at a 55% efficiency. 
After the GE efficiency of working dosage was characterized in embryonic stage, 
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it also needed to be examined in adult stage. A total of 400 medaka embryos at the 
1-cell stage were injected with 100 ng/μl of TALEN mRNAs. There were 122 of 
these injected embryos brought up into adulthood. In order to keep the fish alive to 
establish GE family, autopsy examination was performed to screen for adult fish that 
carry GE alleles. Fin clips were sampled and subjected to genotyping by PCR-HMA. 
It was found that 29 of the F0 fish exhibited heteroduplex bands in the assay, 
indicating they were putative founder animals (Fig. 3.3B).  Various heteroduplex 
bands formed between GE and WT alleles showed retarded mobility compared to the 
homoduplex bands. Besides GD-containing heteroduplex bands, a faint 
GD-Homoduplex band may also be visible in certain F0 fish such as fish #14 and 
#19. Taken together, injection with 100 ng/μl of TALEN mRNAs is capable of 





Figure 3.4. Genotyping of GE alleles. Embryos injected with 100 ng/μl mRNAs 
were analyzed for heteroduplex formation by using PAGE. (A) Individual embryos 
at 7 dpf. (B) Representative F0 adult fish from injected embryos. ctl, non-injected 
control fish. (C) F1 progeny adults from founder fish #1 and #3. Heteroduplex (Ht) 
bands containing GE alleles, and homoduplex (Hm) WT allele (WT) and GE alleles 
(GD) are indicated. Arrowheads depict Hm of GE alleles in (B and C). m, DNA size 




3.1.5. Germline transmission 
F0 fish #1, #3 #19 and #58 derived from TALEN-injected embryos grew to 
adulthood. They were crossed with WT fish of opposite sexes, and the resultant 
progeny were examined for germline transmission. All of them were confirmed to be 
founders, as they transmitted GE alleles to their F1 progenies (Table 2). Specifically, 
founder fish #1 was a female and transmitted a GE allele to 9 out of 84 progenies, 
demonstrating a ~11% germline transmission rate. Founder fish #3 transmitted a GE 
allele to 2 out of 28 F1 progenies, thus demonstrating a ~7% germline transmission 
rate. Founder fish #19 has transmitted a GE allele to 2 out of 18 F1 progenies, 
producing a ~11% germline transmission rate. Founder fish #58 transmitted a GE 
allele to 2 out of 15 F1 progeny, giving a ~13% rate of germline transmission. These 
data suggest that TALEN is able to produce a high GE efficiency in both the soma 
and germline. 
Importantly, the relative abundance or intensity of GE PCR products (i.e. 
heteroduplex band and homoduplex band of the GE allele) was comparable to that of 
the WT PCR product (homoduplex of WT allele) in the progeny of both founder fish 
#1 and #3 (Fig. 4C). This observation is in accordance with germline transmission of 
GE alleles and production of heterozygous F1 animals. Taken together, TALENs are 











#1 A4D7 A3 10.7% (9/84) 
#3 N/D 
2)
 D10 7.7% (2/26) 
#7 D5 N/D N/D (0/28) 
#19 D4/A14D8 A1D11 11% (2/18) 
#58 A4D15 D8 13% (2/15) 
1)
 A, addition; D, Deletion. 
2)
 N/D, Not Detected. 
 
3.1.6. Variable targeted alleles 
Sequencing of cloned PCR products from gel-recovered heteroduplex bands 
validated the GE events. The F1 fish fins were sampled and subjected to PCR-HMA. 
GE alleles with various alterations were identified, which fall into three major 
categories, namely addition (alleles with added nucleotide), deletion (deleted 
nucleotide), and compound alteration (a combination of addition and deletion). Up to 
10 different GE alleles were found in 6 F0 fish (Fig. 3.5). In the fin clip samples, 
founder fish #13, #15 and #19 have deletion GE alleles missing 14, 11 and 4 nt, 
respectively. Founder fish #19 and #58 have compound GE alleles containing both 
addition and deletion.  
The GD-positive progeny of founder fish #1 produced two heteroduplex bands 
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besides a major homoduplex band of the WT allele (Fig. 3.4C), indicating the 
presence of one or two altered alleles, since one loop formed by mismatching PCR 
products may generate one or two heteroduplex bands depending on DNA 
configuration (Chen et al., 2012). Sequencing of cloned PCR products revealed the 
presence of one and same allele, namely A4D7, in all of the 9 progenies. In A4D7, a 
region of 7 nt within the TALEN target sequence is replaced by 4 nt, leading to a net 
loss of 3 nt (Fig. 3.5). Notably, this germline-transmitted allele is different from the 
somatic GE allele A3 in the fin of the founder (Fig. 3.5), indicating that they were 
products of two independent GE events. PCR-HMA of the progeny of founder fish 
#3 produced one heteroduplex band and one homoduplex band of the GE allele 
besides a homoduplex band of the WT allele. Sequencing of the PCR product 
revealed that the GE allele in the founder fish #1 progenies had a deletion of 10 nt 
(D10). What deserves being noted is that autopsy of these progenies’ founder #3 
possesses only the WT allele, showing no detectable GE event in the fin (Fig. 3.5), 
which indicates that allele D10 was generated in the PGCs after the separation of 





Figure 3.5. Sequence analysis of GE alleles. DNA was extracted from the fin of 
adult fish from TALEN-injected embryos or F1 progeny fish. Sequences shown here 
are for the WT and GE alleles within the target site with the spacer being highlighted. 
Small letter cases indicate introduced sequence substitutions. A, addition; D, deletion. 
Numerals after A or D indicate the numbers of nt added or deleted. Notably, fish #19 
had two different GE alleles in the fin, fish #1 had a GE allele in the fin. All of  #1, 
#19 and #58 transmitted a different allele to the F1 progeny. Fish #3 transmitted a 
GE allele, namely D10, to the F1 progeny without showing a detectable GE allele in 
the fin. 
 
3.1.7. Family establishment 
Fish derived from TALEN-injected embryos often developed into fertile female 
and male adults. Families of dnd GE fish should be established to facilitate the 
phenotypic analysis. However, F1 fish often produce progenies that carry different 
GE alleles other than the alleles found in fin clip autopsies. Therefore, F1 fish was 
chosen to be the pool of family founders and a closer inspection on the sequences of 
altered dnd alleles was needed to predict how those alleles affect the protein. 
In the progenies of founder #1, the germline-transmitted allele A3 has 3 more nt 
in the mRNA of dnd, which was confirmed by cloning and sequencing of dnd 
transcript using the cDNA. Thus the mutation would not affect the open reading 
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frame of the gene, so it will still translate into a full length Dnd isoform, except that 
it contains one more amino acid (Fig. 3.6, second). The additional amino acid is not 
within the conserved box of RRM, showing a less possibility for it to interrupt Dnd’s 
biological function. Therefore, the F1 fish that carry GE allele A3 were chosen to 
establish dnd GE family dgd1 as a non-frame-shift mutant. 
In the progenies of founder #3, the germline-transmitted allele D10 has 10 fewer 
nt in the mRNA of dnd and thus represents a frame-shift mutation, which will affect 
the translation of Dnd. This was also confirmed by cloning and sequencing of dnd 
transcript using the cDNA of this family. The predicted protein product of the D10 
allele is only 80 amino acids long and only has the first 48 amino acids correct (Fig. 
3.6, third). This means the RRM is completely removed from the protein. Therefore, 
the F1 fish that carry GE allele D10 were chosen to establish dnd GE family dgd2 as 





Figure 3.6. Schematic mRNA and protein products of GE alleles. Shown are the 
predicted mRNA (line) and protein (thick arrow) products of wild type and altered 
alleles. The grey bars indicate the positions of the alterations. The genuine Dnd 
protein is depicted in black within the protein arrow and the nonsense part of the 
protein products are depicted in red. The #1 founder carries and passes the 
non-frame-shift GE allele A3, producing a Dnd with one additional amino acid. The 
#3 and #58 founders carry and pass the GE alleles with 8- and 10-bp deletion, 




In conclusion, TALENs has been proved to be proficient for inducing germline 
and soma GE events at a high efficiency during medaka embryonic development by 
direct introduction in to the embryos via microinjection. These GE events include 
various targeted alleles that have different alterations, which lead to point mutation, 
in-frame mutation or frame-shift mutations. These GE alleles have been proved to be 
inheritable to progenies of the founders and sometimes the inherited alleles are 
different from the somatic sample of the founders due to chimeric state of the 
founders. The progeny fish heterozygous for either maternally or paternally inherited 
A3 or D10 alleles were found to have a normal somatic development and growth to 
their control siblings. These fish also have the ability to produce offspring. This 





3.2.  Phenotypic analysis of dnd knockouts 
In order to observe the phenotype of loss of both alleles of dnd, F1 fish of both 
sexes from the same family were paired together to produce F2 fish. The embryos 
produced from these mating were collected and observed carefully each and every 
day during the embryonic development. For these F2 embryos, it was anticipated that 
one fourth of them are homozygous for the dnd mutant allele that their founders 
carry, which means they are dnd knockout fish (Fig. 3.7A). Thus, if there were any 
phenotypes, they were probably to be found only in one fourth of the embryos 
produced. However, under white light stereomicroscope, there were no obvious 
phenotypes found. This confirmed the hypothesis that loss of dnd will not affect 
somatic development based on the fact that dnd is a germline specific gene as 
mentioned. The phenotype should be related to the development of germline cells 
and organs. Therefore, further investigation into the phenotype in germline, such as 




3.2.1. dnd-deficient adults are sterile and show secondary sexual 
characteristics 
Embryos collected from dnd
+/-
 parents from dgd1 and dgd2 families were raised 
to adulthood. The fish hatched from these embryos were screened for homozygous 
GE fish after they matured (Fig. 3.7 and Fig. 3.8).  
 
Figure 3.7. Progeny screening of family dgd1. F2 fish of dgd1 family was screened 
after raised to adulthood. (A) Fish were produced by crossing two dnd
WT/A3
 fish. The 
projected  Mendel segregation is shown. (B) The F2 fish genomic DNA were 
sampled from the end of caudal fin, and subjected to PCR. The PCR products were 
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subjected to PAGE to reveal the heteroduplex bands lagging behind the wild type 
bands. The samples exhibited heteroduplex bands are heteroduplex for the A3 allele. 
(C) The F2 fish screening aims for homoduplex fish. The samples showed only 
homoduplex bands in the first PAGE were mixed with PCR products of wild type 
genomic DNA, denatured and re-annealed, thus the samples homogeneous for A3 
allele will exhibit heteroduplex bands now. As shown, samples number 5, 25, 30 and 
31 showed heteroduplex bands and were homozygous for A3 alleles. 
 
 
Figure 3.8. Progeny screening of family dgd2. Similar to dgd1 family, the F2 fish 
homozygous for D10 alleles were also screened out using two rounds of PCR-HMA. 
(A) The PCR-HMA of dgd2 F2 fish. (B) The second PCR-HMA using PCR products 
of wild type genomic DNA to form heteroduplex bands with the samples 




X/Y genotype was also analyzed by using genomic PCR of dmrt1y using the 
genomic DNA from caudal fin autopsy (data not shown). All the homozygous 
knockouts looked the same as their wild type counterparts, thus had the secondary 
sexual characteristics corresponding with their genomic sex (Fig. 3.9). Specifically, 
the fifth dorsal fin ray of X/Y genotypes wre further separated than that of the X/X 
ones (Fig. 3.9B); and the last anal fin ray of X/Y genotypes were also further 
separated as compared to that of the X/X ones (Fig. 3.9C). 
The homozygous knockouts were not able to spawn after paired with each other. 
Wild type fish that were spawning or making females spawn were used to pair with 
the homozygous fish of opposite sex. Still, there was no spawning of eggs. In the 
fertility test, the fish were isolated in the afternoon and paired in the next morning. 
The results were observed 30 min later by checking if there were any embryos 
attached to the belly of the female. Because human presence would interfere with the 
mating of the fish, usually scaring them to a corner, the mating process wasn’t 
observed during the fertility test. Subsequently, a digital camera was used to record 
the courtship and mating of the fish. The record showed that after the male kept 
performing courting towards the female, which is chasing to the tail in this case, they 
mated and the female spawned (Fig. 3.10B, D). However, if the female was replaced 
with a dnd-deficient one, the male lost the desire to chase after the female (Fig. 
3.10C). On the other hand, if the male was replaced with a dnd-deficient one, it 




Figure 3.9. Sexuality of dnd-deficient fish. (A) Shown is sexually dimorphic color 
patterns in whole fish. (B) Dorsal fin in large magnification, highlighting sexual 
dimorphism. As compared to female fish, in both the dnd deficient and wild type fish, 




 fin rays. (C) Anal fin 
in large magnification, highlighting sexual dimorphism. As compared to female fish, 
in both the dnd deficient and wild type fish, the anal fin of male fish showed one fin 





Figure 3.10. Courtship behavior of dnd deficient fish. Mating videos were 
recorded for the purpose of observing the courtships. Shown are the screenshots of 
the videos. As shown, the dnd
-/-
X/Y showed no interest in WT-X/X (A), while the 
WT-X/Y kept chasing after WT-X/X (B). Similarly, the WT-X/Y didn’t show any 
interest in the dnd
-/-
X/X fish (C), in contrast to the wild type fish pair (D). 
In conclusion, the dnd-deficient fish of both sexes were not able to give rise to 
progeny and male fish couldn’t perform courtship to female while female fish 
couldn’t attract courtship from male. 
3.2.2. Loss of dnd
 
leads to loss of germ cells during embryonic development 
Subsequently, the PGCs were checked during embryonic development, since 
knockdown of dnd leads to PGC death during embryogenesis in zebrafish, which 
could also be true in medaka and have led to the infertility. Specifically, gfp mRNA 
with nanos 3’-UTR (gfp:nos-3’-UTR) was used to label the PGCs via 1-cell-stage 
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microinjection (Fig. 3.11). Because this labeling method utilizes the targeted 
clearance of mRNAs with nanos 3’-UTR in somatic cell lineage by microRNAs 
(Ketting, 2007), the mRNA injected will not be degraded in the embryonic stem cells 
before the separation of soma and germline, and survive only in the PGCs after the 
separation. This way, the injected mRNAs will be specifically expressed in PGCs, 
labeling them with GFP. However, the GFP translated during early embryonic 
development will be inherited by the somatic lineage and last for a while, for the 
clearance mechanism only interacts with the mRNAs. This leads to the formation of 
a GFP background and makes the nanos 3’UTR of no use in restricting the GFP 
signal in PGCs in early stages of embryos. As the background GFP degrades and the 
gfp mRNAs in PGCs continue to produce germline-specific GFP, the observation of 
PGCs is more and more eminent. 
 
Figure 3.11. Flowchart of labeling PGCs with gfp mRNA with nanos 3’-UTR. F2 
fish heterozygous for GE alleles were crossed with each other. The produced 
embryos were injected with gfp:nos1-3’-UTR mRNAs and observed for PGCs. Note 





After the F2 embryos of dgd1 and dgd2 family were injected with the gfp mRNA 
as described above, they were observed under fluorescence stereomicroscope daily. 
The PGCs in the embryos of dgd1 family were completely normal through the 
observation period from 2- to 10-dpf as compared to wild type controls (data not 
shown). However, the PGCs in the embryos of dgd2 family only seemed normal for 
the first 2 to 3 days. On the third to fifth days post fertilization, the GFP labeled 
PGCs of some embryos were found to start disappearing (Fig. 3.12). The 
disappearance of GFP signal indicated that the PGCs either simply died out or 
changed their lineage to soma, which no longer sustain the protection for 
gfp:nos-3’-UTR. All of the PGCs in those embryos that have phenotype would 




Figure 3.12. Observing PGCs labeled with gfp mRNA with nanos 3’-UTR. The 
phenotype was obviously revealed upon 5
th
 day of embryonic development. The top 
6 figures show the wild type embryo with the PGCs in the gonad. The bottom 6 
figures show the phenotype of dnd 
-/-
 embryos with severely decreased PGC number 
in the gonad. 
The start point of this observation is stage 21 (1 day 10 hr, or 34 hr post 
fertilization), when there are 6 somites in the embryo during the second day of 
development. The reason is that only from this point the PGCs are clearly visible, 
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because they align dorso-bilaterally along the axis of the embryo instead of being 
among other cells, thus the somatic cells with inherited background GFP do not 
interfere with the PGCs. With a closer observation of the F2 embryos from dgd2 
family, it was found that among the embryos who showed disappearance or severely 
decrease in number of PGCs upon 5-dpf (Fig. 3.13D and D’, Fig. 14B, B’, D and D’), 
some of the embryos showed impaired PGCs with dimmer GPF signal as early as 
2-dpf (Fig. 3.13C and C’). In some other embryos, impaired PGC number was 
observed together with several PGCs with retarded migration (Fig. 3.14A and A’). 
However, some embryos showed no obvious phenotype at 2-dpf (Fig. 3.14C and C’) 
even they later showed disappearance of PGCs at 5-dpf (Fig. 3.14D and D’). As the 
embryos develop, the PGCs continued to migrate to the gonad but many of them 
gradually disappeared in this process. From these observations, it can be concluded 
that some of the embryos produced by parents heterozygous for dnd D10 showed a 
phenotype of decreasing PGC number as early as 2-dpf, which finally led to the 












early as 2 dpf, 
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migration. (A) A 
2-dpf embryo 
with 5 PGCs 
(arrows) that are 
not in the normal 
position. (A’) 
Enlarged view of 
the PGCs, note 
the number of 
them is also 
decreased. (B) 
The 5-dpf photo 
of the same 
embryo, arrowed 
is the PGC still 
with GFP signal 
that have not 
migrated 
properly. (B’) 
Enlarged view of 
the gonad, no 
PGCs. (C) A 
2-dpf embryo 
that shows no 
obvious 
phenotype. (C’) 
Enlarged view of 
the PGCs. (D) 
The 5-dpf photo 
of the same embryo that shows phenotype. Note a cell with GFP signal is found 
(arrow), could be a PGC with impaired migration. (D’) Enlarged view of the gonad 




At this point, it can only be proposed that the embryos with a loss of PGC 
phenotype are homozygous for the dnd-deficient mutant allele D10. In order to 
confirm that the phenotypes are truly caused by the loss of functional Dnd, 
genotyping of the embryos with phenotypes were performed. In the PCR-HMA, all 
the amplicons from embryos with phenotype turned out to be a unified single band, 
indicating a homologous composition of the alleles (Fig. 3.15A). Subsequently, PCR 
products from wild type alleles were added to the ones from samples. A denaturing 
and annealing procedure was used to create heteroduplex of sample PCR products 
and wild type ones. The re-annealed PCR products were then used to perform 
another HMA. The second HMA revealed that the dnd alleles in the samples were 
different from the wild type, and they exhibited the same heteroduplex pattern as the 
D10 alleles (Fig. 3.15B). Sequencing results of the samples’ PCR products 
confirmed they were D10 alleles. These results showed that all the embryos with 
impaired PGCs were proved to be of dnd
-/-
 genotype. 
Overall, some of the embryos produced by the mating of F1 fish, which were 
heterozygous for dnd D10 mutant allele, showed impaired PGC numbers as early as 
stage 21, and these embryos’ PGCs continued to disappear during the embryonic 
development. All of the PGCs in these embryos disappeared within 7 days post 
fertilization. These embryos were then confirmed to be homozygous for the dnd D10 
mutation. In order to further characterize the phenotype of impaired PGC number at 
stage 21, additional investigation with the ability to give a higher resolution of the 




Figure 3.15. Embryos showing phenotypes were proven as dnd
-/-
. Eight of the 
embryos with phenotypes were subjected to genomic DNA extraction and 
genotyping. Their genotypes were confirmed to be dnd
-/-
, indicating the phenotypes 
were caused by homozygous loss of dnd. (A) Shown is the PCR-HMA by PAGE 
result, indicating the genomic DNA only consists of one kind of dnd allele. (B) 
Shown is the second HMA result of the eight embryos after mixing with wild type 
dnd PCR product and re-annealing. The heteroduplex bands have the same pattern 
with the dgd2 F1 fish, proving the existence of D10 allele. 
3.2.3. dnd-deficient adults have severely underdeveloped gonads 
Provided that the germ cells of dnd-deficient fish had all disappeared during 
embryonic development, and the adults were all sterile, it was very likely that their 
gonads were affected. Therefore, those fish were dissected after genotyping, fertility 
test and photograph taking. When the trunks of the fish were opened from the ventral 
side, no ovaries or testes were revealed. It took very close and careful observations 
for one to find a very thin and tube-like organ within the area where normally 
ovaries and testes would locate. These organs were found to link to the gonadopore 
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when I was trying to isolate them by pulling them away from the fish. The found 
organs were likely to be the gonads without germ cells involved in their development 
and looked the same regardless of the genomic sex (Fig. 3. 16A and B). 
 
Figure 3.16. Primary sexuality of dnd-deficient fish. Morphology of gonads from 
fish of different genotypes. Note that the scale bars are different in size for 
underdeveloped gonads and the wild type ones. Thus underdeveloped gonads of dnd 
deficient fish are much smaller and thinner than the wild type ones. They are roughly 
half the length of the wild type ones. 
3.2.4. Gene expression pattern of dnd-deficient gonads 
Markers of medaka germline were examined in the dnd-deficient gonads. 
Specifically, the expressions of dazl and vasa, which are expressed in germ line stem 
cells of both sex, and dmy, which is expressed in male germ line stem cells, were 
examined by using RT-PCR. However, no germline markers were detected in the 
dnd-deficient gonads (Fig. 3.17). Subsequently, sox9b, a marker for gonadal somatic 
cells, was also examined. However, sox9b was not detectable, either. The results of 
routine RT-PCR indicated that the quality and amount of total RNAs extracted from 
the tiny gonads by Trizol method were not good enough. So I decided to use RNeasy 
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micro kit and digital droplet-PCR (dd-PCR) for higher recover rate of total RNA and 
more precise quantification.  
 
Figure 3.17. RT-PCR results of the gonads of dnd deficient fish. As shown, the 
gonads of dnd deficient fish lost the germline markers completely, which include 
dazl, vasa, dmy. Sox9b, a gonadal somatic cell marker, wasn’t detected in the dnd 
deficient fish. 
Indeed, the combination of RNeasy micro kit and dd-PCR gave rise to better results. 
Still, no germline stem cell markers were detectable in those gonads (data not 
shown), while some somatic gonadal markers were detectable (Figure 3.18). For 
example, ovary somatic marker aromatase and foxl2 were detectable. However, 
while the aromatase’s mRNA levels of the underdeveloped gonads were much lower 
than that of the wildtype ones, the foxl2’s mRNA levels of the underdeveloped 
gonads were much higher than that of the wildtype ones, but the X/X dnd-deficient 
gonads still showed higher levels of mRNA than the X/Y ones. For male somatic 
gonadal markers, dmrt1 showed similar transcription level in both sexes of 
dnd-deficient gonads, which were both one fifth of the wildtype male one. High 
transcription level of gsdf in wildtype testis was not seen in either genotypes of 
dnd-deficient gonads. The mRNA levels of gsdf in dnd-deficient gonads were similar 
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to the wildtype counterparts. However, the data is not repeated and consolidated for 
now. Further repeats will be done to consolidate the data and give a clearer view of 




   
   
 
Figure 3.18. dd-PCR results of the gonads of dnd deficient fish. As shown, the 
gonads of dnd deficient fish lost the germline markers completely, which include 














































































3.2.5. Loss of germ cells phenotype correlates with dnd quantitatively 
The gfp:nos-3’-UTR labeling method comes with an inherent defect, which is 
the back ground created during early embryonic stages before the separation of 
germline and soma, as mentioned before. This background greatly reduced the signal 
to noise ratio, thus reducing the resolution of the image. However, the image quality 
needed to be improved to enable more detailed analysis of the phenotype caused by 
loss of dnd in the embryos. Therefore, whole-mount in situ hybridization of vasa, 
also a germline-specific gene, was used to label the PGCs in embryos instead of GFP. 
Subsequently, time-lapsed whole-mount in situ hybridization with the probe for vasa 
(vasa-WISH) was used to dissect the process of disappearance of PGCs (Fig. 3.18). 
Time points were selected as 34-hpf (embryonic stage 21), 2-dpf, 3-dpf and 4-dpf. 
 
Figure 3.19. Flowchart of examination of the correlation between PGC number 
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and dnd genotype. This flowchart shows how the experiment was performed for 
combined whole mount in situ hybridization and genotyping using capillary 
electrophoresis.  
In contrast to the gfp:nos-3’-UTR-labeled fluorescent images of the stage 21 
embryos, the images of the in situ hybridization results had a very high resolution so 
that the single PGCs were distinguishable from each other. Because the PGCs align 
bilaterally along the axis of the embryos at stage 21 and generally disperse in one 
layer within this area, the PGC number can be counted (Fig. 3.19A to D). The in situ 
hybridization was performed on a total of 49 embryos spawned by dnd
+/-
 parents and 
7 embryos spawned by wild type parents as a control. In the assay, the wild 
type-produced embryos showed an average PGC number of 41 (Fig. 3.19E). On the 
other hand, the dnd
+/-
-produced embryos showed an average PGC number of 25. 
Among these dnd
+/-
-produced embryos, some had few PGCs while others had a 
number of PGCs, which is comparable to that of wild type-produced embryos. This 
finding provoked the analysis of the genotypes of these embryos by lysing the 
embryos that had gone through in situ hybridization and extracting their genomic 
DNAs for PCR and subsequent genotyping method. Because PCR-capillary 
electrophoresis (PCR-CE) was more convenient than PCR-HMA but can only be 
used in F1 fish when the mutant allele of dnd was an investigated one, this method 
was chosen instead of PCR-HMA for the genotyping of those embryos. In PCR-CE, 
the dnd
+/+
 embryos showed a single peak at 196 bp, representing the wild type PCR 
product; the dnd
-/-
 embryos showed a single peak at 186 bp, representing the D10 
allele’s PCR product; the dnd+/- embryos showed both PCR products due to the 
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heterozygosity of the sample (Fig. 3.19F). 
 
Figure 3.20. dnd dosage and PGC number in medaka embryos. Embryos from 
crosses between fish herterozygous for a mutant dnd allele (D10) were collected at 
stage 21 (6 somites), analyzed with WISH by using an antisense vasa riboprobe for 
counting the number of PGCs and genotyped. (A-D) Representative embryos of 
different genotypes, showing that somatic development is normal until stage 21. 
(A’-D’) Large magnifications of areas boxed in A-D, highlighting the number and 
positions of PGCs. (E) Statistic analysis of PGC numbers. Numerals within columns 
refer to the numbers of embryos analyzed. (F) Representative result of genotyping of 
the embryos. 
It turned out that the result of PGC number in the stage 21 embryos correlated 
with the genotypes of the embryos (Fig. 3.19E). Interestingly, as compared with the 
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wild type average PGC number of 41, the dnd
+/+
 embryos from dnd
+/-
 parents 
showed an average PGC number of 28, which is about one-fourth less than their 
counter parts from wild type parents. Although the genotypes of these two groups of 
embryos were the same, the PGC numbers diverged. The only difference between 
them was the parents’ genotypes. For the dnd+/- embryos from dnd+/- parents, they 





 embryos had only one copy of functional genomic dnd. However, for 
the dnd
-/-
 embryos, the PGC number was averagely 13, which was much lower than 
the previous ones. 
The difference of PGC number in stage 21 between wildtype-born embryos and 
dnd heterozygotes-born ones indicates that maternal effect may have been playing a 
role here. Therefore, 30 embryos from WT parents and another 30 from dgd2
+/-
 
parents were smashed and the total RNA was extracted and subjected to dd-PCR 
using dnd and actin primers. The quantity of dnd mRNA of each group indeed 
differed and the WT group showed roughly twice the amount of dgd2
+/-
 group. This 





Figure 3.21. Quantification of maternal dnd mRNA in WT-born and 
dgd2
+/-
-born embryos. 30 embryos of each group were smashed and the total RNA 
was extracted. Dd-PCR results of dnd normalized to actin are shown above. 
Collectively, the PGC number of stage 21 embryos correlated with two 
parameters: the genotypes of the parents and their own genotypes. Generally, the 
embryos from wild type parents showed more PGCs than those from dnd
+/-
 parents, 
which is caused by the different amount of maternal dnd mRNA. Specifically, within 






 embryos showed more PGCs 
than dnd
-/-
 ones, which is possibly caused by the different level of zygotic dnd 
mRNA synthesis. 
3.2.6. Vasa-WISH reveals earlier onset of disappearance of PGCs 
Vasa-WISH was also performed on the 2-, 3- and 4-dpf embryos as described. 
Surprisingly, unlike results obtained by GFP-labeling method, vasa-WISH results 






















decrease of PGC number (Fig. 3.20A and A’), as compared to wild type embryos 
(Fig. 3.20D and D’). 3-dpf embryos also showed similar phenotype (Fig. 3.20B and 
B’), as compared to wild type embryos (Fig 3.20E and E’). In 3-dpf embryos, the 
decrease of PGC number is more prominent, since the remaining number of PGCs in 
the dnd-deficient embryos is further decreased, while number of PGCs in the wild 
type embryos is increasing in line with embryonic development. In the vasa-WISH 
results of 4-dpf embryos, complete ablation of PGCs was observed (Fig. 3.20C and 
C’), as compared to wild type embryos (Fig. 3.20D and D’). This is earlier than the 




Figure 3.22. In situ hybridization of 2 to 4 days dnd
-/-
 embryos. As shown, 2-dpf 
embryo with dnd
-/-
 genotype showed severely decreased PGC number (A, A’), as 
compared to WT one (D, D’). 3-dpf dnd-/- embryos also showed the disappearance of 
most PGCs (B, B’), but not the wild type ones (E, E’). 4-dpf dnd-/- embryo showed 




3.2.7. dnd mRNA not only rescued the phenotype but also induced gain of 
function 
In order to confirm that the phenotypes observed above were genuinely caused 
by the loss of Dnd, rescue experiment was performed (Fig. 3.21, top). If the 
observed phenotypes could be rescued by externally introduced Dnd, it could be 
concluded that they were caused by loss of Dnd. Embryos produced by dnd
+/-
 fish 
were chosen as the subjects to be rescued. In vitro transcribed mRNA encoding for a 
fusion protein of Dnd and GFP were used to rescue the embryos. In the same time, 
the PGCs were visible because of fused GFP for the convenience of observation. 
This mRNA (dnd:gfp:dnd-3’-UTR) included a 3’-UTR which was derived from gene 
dnd itself, ensuring genuine germline-expression of Dnd. 
One-cell stage embryos from the heterozygous parents were injected with 
dnd:gfp:dnd-3’-UTR. However, the ones injected with an mRNA concentration of 
100 showed a very low survival rate of 6% only upon gastrulation (Fig. 3.21, 
bottom). The reason for initially using 100 ng/µl was that the same concentration 
used for gfp:nos-3’-UTR didn’t cause any embryo deaths. The concentration was 
halved to 50 ng/µl and the survival rate for the microinjection experiment went up to 
39%. It was expected that only one fourth of the embryos were dnd
-/-
 ones – targets 
for rescue (Fig. 21, top). Therefore, a 39% survival rate means that only 10% of the 
experimented embryos would be surviving dnd
-/-
 ones, making this concentration 
unsatisfactory. The concentration was then halved again to 25 ng/µl. With this 
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concentration, the survival rate increased to almost 90%, which was satisfactory. 
 
Figure 3.23. Flowchart of rescuing loss of dnd phenotype and the survival rates 
of injecting dnd:gfp-dnd-3’-UTR. Top shows the flowchart of rescuing experiment. 
Bottom shows the survival rates increase to a satisfied level after the dosage has 
been decreased to 25 ng/µl. 
A total of 50 embryos produced by dnd
+/-
 parents were injected with 25 ng/µl 
dnd:gfp:dnd-3’-UTR and 100 ng/µl gfp:nos-3’-UTR. Another 50 embryos produced 
by dnd
+/-
 parents were injected with 100 ng/µl gfp:nos-3’-UTR only, serving as 
control. These embryos were observed daily under fluorescent microscopy. The same 
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as previous experiments, some of the embryos from control group started to lose 
PGCs from day two post fertilization (Fig. 3.22B and B’), while others remain 
normal (Fig. 3.22A and A’). However, none of the embryos from experiment group 
showed losing of PGCs. In contrast, they exhibited increased PGC numbers (Fig. 
3.22C and C’). When the embryos were observed 5 days post fertilization and 
injection, PGCs had already migrated into the gonads in most embryos of the control 
group (Fig. 3.22D and D’), but 12 of them exhibited loss of all germ cells (Fig. 
3.22E and E’). In the same time, all of the experiment group’s embryos exhibited 
excessive amounts of germ cells in the gonad (Fig. 3.22F and F’). Subsequently, all 
the embryos were genotyped using PCR-HMA. The results showed that the 12 germ 
cell-less embryos from the control group were all of dnd
-/-
 genotypes (data not 
shown) and there were 13 dnd
-/- 
embryos out of the 50 embryos with excessive PGCs 
from the experiment group. 
Collectively, externally introduced dnd mRNA not only successfully prevented 
the loss of germ cells phenotype during embryonic development, but also enhanced 
the amounts of germ cells in the embryos. This result indicated that this phenotype is 




Figure 3.24. Rescue the loss of PGC phenotype in early stage embryos with dnd 
mRNA. The left and middle columns show gfp-nos-3’UTR-labeled wild type 
embryos (A, A’, D, D’) and embryos with phenotype (B, B’, E, E’). Embryos 
rescued are shown at the right column (C, C’, F, F’). Interestingly, all of the embryos 
rescued showed increased number of PGCs, regardless of the phenotypes. No 




In sum, the efficiency of TALEN-mediated gene editing of dnd was explored 
and determined and the phenotypic results of loss of dnd were characterized. In the 
discussion section, different approaches of programmable nuclease-mediated 
genome engineering will be discussed as compared to this thesis. Moreover, the dnd 





CHAPTER 4 DISCUSSION 
4.1.  Summary of results 
In this thesis, I have: (1) established procedures and parameters for 
TALEN-mediated gene editing on the chromosomal locus dnd in medaka embryos 
via mRNA injection; (2) explored and characterized the phenotype of dnd deficiency 
in medaka embryos and fish; (3) provided evidence for a quantitative correlation 
between dnd and PGC number, indicating an important role of dnd in orchestrating 
PGC formation.  
It is shown that the survival rate and GE efficiency are dependent on the dose of 
injected TALEN mRNAs. Specifically, TALENs at an optimal dose of 100 µg/µl is 
able to produce a high survival rate of up to 85% and a GE efficiency of 55% at the 
hatching stage. Both lower and higher dosages produce lower GE efficiency. The 
GD-positive embryos developed normally into fertile female and male adults capable 
of transmitting GE alleles into 7.7 to 13% progeny of the F1 generation. Therefore, 
the TALEN technology is proficient for GE in the soma and germline of medaka 
embryos. These data provide valuable information for TALEN-mediated GE in 
medaka as well as other fish species. 
It is shown that the embryos without genomic dnd, but still with maternal dnd 
mRNA, initially have PGCs and lose them during embryonic development. The 
PGCs in these embryos start to decrease in number since stage 21 and disappear by 
the 5
th
 day post fertilization. The timings of disappearance of PGCs observed by GFP 
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labeling method and vasa-ISH method differs, with the prior lagging about one day. 
The adult dnd deficient fish show infertility and no courtship behavior. The gonads 
of these fish are severely underdeveloped, which are only half of the length of wild 
type ones and extremely thin. These gonads have lost genetic markers for germline 
and gonadal somatic cells. These data provide a platform for further studies on the 





4.2.  Factors that affect TALEN-mediated GE efficiency 
In medaka, direct GE by using the ZFN approach has been reported on the 
transgene gfp (Ansai et al., 2013) and the chromosomal gene gsdf (Zhang et al., 
2014). In both studies, ZFNs produce a wide variety of GE alleles with subtle 
sequence alterations including additions, deletions and compound changes. In this 
thesis, TALENs targeting on the chromosomal locus dnd can also produce similar 
diversity of GE alleles. These results suggest that the TALEN and ZFN approach 
share a common ability to generate a wide variety of allelic alterations in medaka. 
In medaka, gsdf-targeting ZFNs under optimized conditions have produced a 58% 
GE efficiency and a 48% survival rate (Zhang et al., 2014). In this study, 
dnd-targeting TALENs at an optimized dosage have given rise to a 55% GE 
efficiency and an 85% survival rate. More importantly, our results in this study 
demonstrate that all the four fish from TALEN-injected are capable of transmitting a 
GE allele to 7.7~13% of F1 progeny, suggesting a high efficiency in generating 
germline transmitters. These twin studies appear to point to the advantage of 
TALENs over ZFNs in terms of GE efficiency, survival and ease with which that 
TALENs are engineered. This notion is supported by a recent report that the TALEN 
approach is highly efficient for dj-1 GE (Ansai et al., 2013). 
The GE efficiency observed in this thesis peaks at 32% and the germline 
transmission rate ranges from 7.7% to 13%. However, a nearly 100% GE efficiency 
and a germline transmission rate of 43.8%~100% has been obtained on dj-1 GE by 
using TALENs at 50~300 ng/μl (Ansai et al., 2013). Multiple factors may account 
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for such differences in efficiency. For example, it is known that the efficiency of 
TALENs is depending on genomic context, with different target genes producing 
varying efficiencies (Cade et al., 2012). In addition, other differences in the structure 
of TALENs such as the lengths of N- and C-terminus may also influence the 
efficiency. In the following sub-sections, factors affecting the efficiency of TALENs 
will be discussed.  
4.2.1. RVDs 
In the previous sections, it has already been introduced that HD, NI, NN and NG 
are commonly used for designing and constructing new TALENs for targeting 
nucleotides C, A, G and T, respectively. In fact, it has been reported that NK, also an 
abundant RVD, possesses a more specific binding affinity to G than NN (Miller et al., 
2011). In the initial stage of this thesis, a pair of synthesized TALENs, choosing NK 
for the recognition of G, was first used to target gene dnd. The target sequence of 
that pair of TALENs is CATGATGAACTTCA and TGGCGTAAGCGAAG. 
However, that pair of TALENs didn’t induce detectable GE in medaka embryos after 
many trials. This indicated that NK may not be a genuine good RVD for G 
recognition. Thus, I chose NN for G recognition and constructed the TALEN pair 
reported in the results section, finally getting satisfactory GE efficiency.  
Later, a report re-examining both the specificity and the binding efficiency of 
the potential RVDs was published on Nature Biotechnology (Streubel et al., 2012), 
explaining why NK was not suitable for my first pair of TALENs. They first used 
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poly A-, C-, G- or T-boxes of 15 bp long to examine each RVDs’ binding efficiency 
by constructing TALEs consisting of 15 NI, HD, NN, NG, NS, N* or HG and testing 
all these TALEs on the four poly nucleotide boxes. It was shown that only HD 
targeting C and NN targeting G showed a strong reporter gene expression (Fig. 4.1a). 
Other pairing of poly RVDs and poly nucleotide boxes only resulted in very weak 
expression of the reporter gene. This result indicates that only the binding of HD to 
C and NN to G is strong enough to trigger stable TALE binding to its target sequence. 
It was also shown that, in the case without NN or HD, 3 NK or 3 NH were not 
enough for the targeting of TALEs (Fig. 4.1c). Furthermore, 6 NH but not 6 NK were 
enough for the targeting of TALEs in this scenario (Fig. 4.1d). This result indicates 
that NH is an intermediate RVD for G and NK is a very weak one. Finally, 
specificity test showed that NN in TALEs that already consisting 3 HD not only 
exhibit strong targeting efficiency to G, but also to A (Fig. 4.1e). On the other hand, 
when NH or NK were used instead, the targeting efficiency is very specific to G 
only. 
Collectively, for further TALEN RVD designs, 3 to 4 strong RVD (NN or HD) 
should be included to ensure the binding efficiency and NH should be used for G for 
the binding specificity if the first rule has already been met. In the case of lack of 




Figure 4.1. TALE RVD specificities and efficiencies. Adapted from (Streubel et al., 
2012) 
4.2.2. C- and N- terminus of TALE architecture 
In this thesis, the TALENs consist of full length of C- and N-terminus, because 
the truncation experiment of TALENs was not published when this project initiated. 
However, longer TALENs without truncation may have contributed to the lower GE 
efficiency. The first TALEN architecture contains a 288 aa of N-terminus and a 231 
98 
 
aa C-terminus (Cermak et al., 2010). The first 136 aa of the N-terminus was found to 
help the TALEs to enter plant cells (Szurek et al., 2002b). Therefore, a TALE with 
only 153 aa N-terminus can be created, namely Δ153. A smaller TALEN architecture 
increases the targeting efficiency per ng/µl, since I didn’t use molar concentration for 
GE efficiency characterization. For C-terminus, the improvement has a bigger 
impact on the GE efficiency, because the C-terminus is responsible for linking DNA 
binding domain to the FokI nuclease. Although I mentioned that different truncations 
in C-terminus didn’t affect GE efficiency according to relevant reports, they actually 
improved the GE efficiency if the spacer is also adjusted according to the length of 
C-terminus (Christian et al., 2012). In a very aggressive version of TALEN 
architecture, only 18 aa were left for the C-terminus, namely NΔ153/C+18. This 
version exhibited 4 times more efficient than the full-length version targeting 14-bp 
spacer (Fig. 4.2). NΔ153/C+18’s efficiency targeting 14-bp spacer is still 2 fold 
higher than the full-length version targeting its optimal spacer, which is 27 bp (Fig. 
4.2). In this thesis, full length TALEN architecture was used, however, the spacer 
was 15 bp, leaving a lower than normal but still satisfactory GE efficiency. This 
explains why the various targeted alleles lack addition types, since addition types of 
GE alleles will induce higher cleavage rate due to elongated spacer, making this kind 




Figure 4.2. TALEN backbone architectures and spacer length optima. Adapted 
from (Christian et al., 2012). 
4.2.3. FokI nucleases 
The innate toxicity of ZFNs and TALENs comes from the off-targeting effect. 
The off-targeting effect comes from the homodimer formation of FokI nucleases in 
high concentration context (Alwin et al., 2005; Porteus and Baltimore, 2003). In 
detail, high concentration of ZFNs or TALENs means high concentration of FokI 
nuclease monomers. These monomers tend to dimerize at genomic locus with only 
one of them binding to the DNA when they are too concentrated, leading to 
off-target cleavages across genome. Some of these off-target cleavages induce 
genome instability, which may finally lead to toxicity to the cells. Therefore, 
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Heterodimer FokI nucleases were computationally designed and tested in cells 
(Szczepek et al., 2007). Asymmetric FokI heterodimers (DD/RR) and FokI 
homodimers with lower binding potential that only cleave after both of the two FokI 
nucleases bind to the DNA (IV/AI) were created and proven to be effective, reducing 
the toxicity by 3 fold (Fig. 4.3). By combining the asymmetric design and the lower 
binding potential design, RV/DA and KV/EA heterodimers were created and proved 
to be not only less toxic but also highly efficient (Mussolino et al., 2011; Szczepek et 
al., 2007). 
 
Figure 4.3. Percentage of highly g-H2AX-positive cells. The percentage represents 
the toxicity. Adapted from (Szczepek et al., 2007). 
In summary, if all these parameters are taken into consideration, 





4.3.  Dnd deficient medaka embryos and adults 
In this thesis, medaka dnd deficient phenotypes were analyzed. Generally, loss 
of Dnd leads to retarded migration or direct death for PGCs, which is in accordance 
to the phenotype of zebrafish dnd knockdown (Weidinger et al., 2003). Dnds in both 
fish models are cell-autonomously essential for the PGC migration and survival. 
Being a germline-specific gene was part of the reason for choosing dnd as the 
TALENs’ target. The disruption of this gene is neither likely to affect the somatic 
development nor to induce embryonic lethality. The TALENs’ toxicity thus can be 
analyzed thoroughly. Indeed, the genotypes of all screened F2 animals revealed that 
dnd
+/- 
fish produced offspring in a Mendelian segregation manner (Table 4.1 and 
table 4.2). 
 


















Table 4.2. Mendelian-segregation inheritance of dnd alleles in F2 fish 
 
Germline transmitters in this thesis were highly mosaic in terms of cells that 
carry a disrupted dnd allele, which can be indicated by the germline transmission 
rate of 7.7 to 13%. Since double-allelic disruption of dnd is expected to cause PGC 
death in F0 fish, this germline transmission rate represents only the percentage of 
cells with single-allelic disruption of dnd in the PGCs of the founders. Thus, F0 
founder fish are mosaic for cells with or without a single GE allele. Since all the 
germ cells containing a single GE allele are expectedly heterozygous before the 
completion of meiosis, they should be capable of normal development during 
embryonic and post-hatching stages. However, such a disrupted allele will stand 
alone in post-meiosis cells. The fact that female, and more importantly, male 
founders are able to transmit a mutant dnd allele to F1 generation strongly suggests 
that genomic dnd is dispensable for germ cell development during the post-meiotic 
haploid phase. 
Interestingly, in observing the disappearance of PGCs in dnd
-/-
 embryos, 
vasa-WISH data showed the disappearance happens between 3 to 4 dpf, however, 
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the GFP labeling data showed the disappearance happens between 4 to 5 dpf. In the 
earlier stages (stage21 and 2-dpf), a bigger portion of the vasa-WISH data showed 
embryos with only few PGCs, which is nearly considered as disappearance. For GFP 
labeled embryos, only a very small portion showed this phenomenon. A possible 
explanation to this phenomenon is that the timing of loss of GFP signal lag behind 
the timing of losing PGC lineage trait. Even a cell dies, the GFP takes time to 
degrade. However, for vasa mRNA, it is expected to be degraded soon after the cell 
die or lose PGC lineage trait. 
4.3.1. PGC number correlates with Dnd dosage 
Dnd and its mRNA are maternally deposited into the embryos (Liu et al., 2009), 
so the dnd
-/-
 embryos produced by heterozygous female are expected to retain Dnd 
until the maternally deposition runs out. According to the results section, dnd 
deficient embryos retained PGCs until 5-dpf, indicating that the decreasing of Dnd 
dosage may have caused the death of PGCs. On the other hand, since the female 
parent of the dnd
-/-
 embryos is heterozygous for a functional dnd allele, it is expected 
that only about half of the normal amount of Dnd can be deposited into the oocytes 
before meiosis. The difference between WT female-produced embryos and dnd
+/-
 
female-produced embryos in PGC numbers at stage 21 indicates a correlation 
between the number of PGCs and the dosage of maternally deposited Dnd. Moreover, 
introduction of external Dnd at one-cell stage by microinjection not only rescue the 
PGC number decrease but also greatly enhance the number of PGCs, supporting the 
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Dnd dosage-PGC number relationship in the other way. However, further 
experiments are needed to prove the coincidence to be a cause and effect relationship: 
Examine the maternal Dnd dosage difference and the Dnd dosage in the PGCs 
during embryonic development. 
4.3.2. Secondary sex characteristics of adult dnd deficient fish 
According to the observation of adult fish, their secondary sex characteristics 
were not different from their wild type counterparts. Since the phenotype of dnd 
deficiency should have been caused by loss of PGCs, the results should be compared 
with the other study that investigated germ cell-loss phenotype, which was 
conducted by Hiromi et al. (Ohta et al., 2007). In that study, they used morpholino 
targeting CXCR4, which is essential for medaka PGC migration, to prevent the 
PGCs from reaching the gonadal primordium, generating germ cell-free fish at an 
efficiency of 32% of injected embryos. However, according to their observation, all 
the germ cell-free fish, including the X/X ones, exhibited male secondary sex 
characteristics. Moreover, PGC-ablated zebrafish also exhibited an all-male 
phenotype (Slanchev et al., 2005). It is unclear why the germ cell-free dnd deficient 
fish in this thesis retain secondary sex characteristics in accordance to their sex 
genotype. There is one important difference between this study and the two referred: 
this study uses knockout system to ablate PGCs, which leads to 100% of PGC 
ablation in dnd
-/-
 fish; the other two use morpholino-mediated knock down system to 
ablate PGCs, which leads to an incomplete suppression of the target gene and 32% 
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of PGC ablation in embryos. The medaka gonads in germ cell-free fish observed by 
Hiromi ei al. were thicker and longer than the ones observed in this study. It is 
possible that knockdown approach was not able to completely remove the PGCs, 
which would leave a very small number of germ cells. According to their 
observation, some X/X embryos originally categorized as germ cell-free developed 
into fertile male fish. They explained this by stating that maybe small amount of 
PGCs escaped observation and led to the male development in an X/X context. This 
explanation would support my hypothesis, that a very small number of germ cells 
also escaped their observation and led to male development in X/X context, however, 
the amount of germ cells are even lower and thus the fish was not fertile. 
 
Figure 4.4. Gonads of wild type and CXCR4 knockdown fish. Adapted from 




CHAPTER 5. CONCLUSION 
In this thesis, TALENs have been found proficient for direct genome editing in 
medaka embryos by one-cell stage microinjection, providing an easy one-step 
method for generation of medaka knockout fish for genetic analyzes. Results of this 
study showed TALENs generated a genome editing efficiency of 23% in F1 adults 
and a germline transmission rate of 7.7 to 13%. Various aspects of the TALENs 
themselves are still able to be improved by new approaches in the development of 
TALEN backbones with higher efficiency and lower toxicity, which have been 
discussed in chapter 4. If the improvements are implemented, the TALENs are 
expected to be an even more convenient tool for genome editing, because lower 
toxicity means larger amount of TALENs can be applied, which means even higher 
efficiency. 
On the other hand, this thesis demonstrates the phenotypes of dnd deficient fish 
in a knockout context. This thesis provided evidences that indicate that PGC number 
correlates with cellular Dnd dosage, since the PGC number decreases with the 
running out of maternal Dnd in dnd
-/-
 embryos and the PGC number increases in the 
Dnd injected embryos. Additionally, the PGC number also correlates with the 
quantity of maternally deposited dnd mRNAs. This thesis also showed that the adult 
dnd-deficient fish exhibit a loss of germ cell phenotype. However, this phenotype is 
not the same as the phenotype observed in morpholino oligo-mediated germ cell 
deficient fish. The secondary sex characteristic is not reversed in X/X dnd-deficient 
fish and the dnd-deficient gonads in this thesis are thinner and shorter than those 
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observed in the morpholino oligo-mediated germ cell deficient gonads. Further 
studies are required to investigate the true reason of the difference in the germ 
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Appendice I. Reagent list 
Acylamide solution, 30%, A:B=29:1, Biorad, CAT#: 161-0156 
Agar, Sigma. 
Agarose, 1st base, molecular biology grade 
Ampicillin, Sigma 
Big-Dye Terminator cycle sequencing kit, Applied Biosystems, CAT#: 4336917 
BSA, Sigma, A9418-100G 
CaCl2•2H2O, Merck 
Chloroform, Merck, CAT#: 1.02445.2500 
Diethylpyrocarbonate (DEPC) 
Dimethyl sulfoxide, Sigma, CAT#: D2650 
EDTA, Sigma 
Ethanol, Merck, CAT#: 1.00983.2500 
Ex Taq and HS Ex Taq polymerase, TaKaRa, CAT#: DRR100E 
Formamide, Molecular biology grade, Calbiochem, CAT#: 344206 
GeneRuler 1-kb DNA ladder, Fermentas, CAT#: SM0311 
Genescan400HD, ABI 
Glacial acetic acid, Merck, CAT#: 100056 
Goat serum, Sigma, CAT#: G9023 
Glycerol, 99.5%, Sigma 
Heparin, Sigma 
Hi-Di-formamide, Life technologies, CAT#: 4311320 
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Hydrogen peroxide, 35% by weight, Riedel-de Haen, CAT#: 18304 
Isopropanol Sinopharm Chemical, CAT#: 19130020 
Kanamycin, Sigma 
KCl, Sigma, CAT#: P5405 
KH2PO4, Merck, CAT#: 529568 
LB powder mix, 1
st
 Base 
Liquid nitrogen, Cryoexpress Singapore 
Methanol, QReC, CAT#: M2097-4-2501 
MgCl2, Sigma 
Mineral oil, Sigma, CAT#:M8410-500ML 
MMLV reverse transcriptase, Thermo, CAT#: EP0352 
MN gel recovery and PCR purification kit NucleoSpin Extract II, Macherey-Nagel, 
CAT#: 740609.250 
MN plasmid midi kit Nucleobond Xtra midi plus, Macherey-Nagel, CAT#: 740412.2 
Na2HPO4, Merck, CAT#: 106566 
NaCl, Sigma 
NaHCO3 Sigma, CAT#: S5761 
NaOH, Sigma 
NBT/BCIP substrate solution, Roche, CAT#: 11681451001 
Paraformaldehyde PFA, Sigma, CAT#: P6148 
PCR primers are synthesized by Sigma, 1st Base or IDT. 
pGEM-T-easy vector system, Promega, CAT#: A1360 
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Phenol red, Sigma, CAT#: P3532 
Phenol solution, Sigma, CAT#: P4557 
Phenol:Chloroform:IAA 25:24:1, Ambion, CAT#: AM9732 
Proteinase K, Invitrogen, CAT#: 25530-015 
Restriction enzymes are purchased from Promega, New England BioLabs and 
Fermentas 
RNase A, Sigma, CAT#: R6513 
RO and Milli-Q water: From Millipore pure water system, Milli-Q water is 
autoclaved for molecular work 
10% SDS solution, Sigma, CAT#: L4522 
Secondary Antibody anti-DIG-AP fab fragments, Roche, CAT#: 11207733910 
T4 DNA ligase, NEB, CAT#: M0202, Invitrogen, CAT#: 15224-025, Promega, 
CAT#: M180A 
Tris-HCl, Sigma 
Trisodium citrate Sigma, CAT#: S4641 
Trizol reagent Invitrogen, CAT#: 15596-026 
Tween 20, Sigma, CAT#: P2287 
tRNA transfer ribonucleic acid, from wheat germ, Sigma, CAT#: R7876 




Appendice II. Coding sequences of pTN1dnd and pTN2dnd 
 
Coding sequence of pTN1dnd: 
1    ATGGCTTCCTCCCCTCCAAAGAAAAAGAGAAAGGTTAGTTGGAAGGACGCAAGTGGTTGGTCTAGAATGCATGCGGATCCCATTCGTCCGCGCAGGCCAA 
101  GTCCTGCCCGCGAGCTTCTGCCCGGACCCCAACCGGATAGGGTTCAGCCGACTGCAGATCGTGGGGTGTCTGCGCCTGCTGGCAGCCCTCTGGATGGCTT 
201  GCCCGCTCGGCGGACGGTGTCCCGGACCCGGCTGCCATCTCCCCCTGCGCCCTCACCTGCGTTCTCGGCGGGCAGCTTCAGCGATCTGCTCCGTCCGTTC 
301  GATCCGTCGCTTCTTGATACATCGCTTCTTGATTCGATGCCTGCCGTCGGCACGCCGCATACAGCGGCTGCCCCAGCAGAGTGGGATGAGGCGCAATCGG 
401  CTCTGCGTGCAGCCGATGACCCGCCACCCACCGTGCGTGTCGCTGTCACTGCCGCGCGGCCGCCGCGCGCCAAGCCGGCCCCGCGACGGCGTGCTGCGCA 
501  ACCCTCCGACGCTTCGCCGGCCGCGCAGGTGGATCTACGCACGCTCGGCTACAGTCAGCAGCAGCAAGAGAAGATCAAACCGAAGGTGCGTTCGACAGTG 
601  GCGCAGCACCACGAGGCACTGGTGGGCCATGGGTTTACACACGCGCACATCGTTGCGCTCAGCCAACACCCGGCAGCGTTAGGGACCGTCGCTGTCACGT 
701  ATCAGCACATAATCACGGCGTTGCCAGAGGCGACACACGAAGACATCGTTGGCGTCGGCAAACAGTGGTCCGGCGCACGCGCCCTGGAGGCCTTGCTCAC 
801  GGATGCGGGGGAGTTGAGAGGTCCGCCGTTACAGTTGGACACAGGCCAACTTGTGAAGATTGCAAAACGTGGCGGCGTGACCGCAATGGAGGCAGTGCAT 

































Coding sequence of pTN2dnd: 
1    ATGGCTTCCTCCCCTCCAAAGAAAAAGAGAAAGGTTAGTTGGAAGGACGCAAGTGGTTGGTCTAGAATGCATGCGGATCCCATTCGTCCGCGCAGGCCAA 
101  GTCCTGCCCGCGAGCTTCTGCCCGGACCCCAACCGGATAGGGTTCAGCCGACTGCAGATCGTGGGGTGTCTGCGCCTGCTGGCAGCCCTCTGGATGGCTT 
201  GCCCGCTCGGCGGACGGTGTCCCGGACCCGGCTGCCATCTCCCCCTGCGCCCTCACCTGCGTTCTCGGCGGGCAGCTTCAGCGATCTGCTCCGTCCGTTC 
301  GATCCGTCGCTTCTTGATACATCGCTTCTTGATTCGATGCCTGCCGTCGGCACGCCGCATACAGCGGCTGCCCCAGCAGAGTGGGATGAGGCGCAATCGG 
401  CTCTGCGTGCAGCCGATGACCCGCCACCCACCGTGCGTGTCGCTGTCACTGCCGCGCGGCCGCCGCGCGCCAAGCCGGCCCCGCGACGGCGTGCTGCGCA 
501  ACCCTCCGACGCTTCGCCGGCCGCGCAGGTGGATCTACGCACGCTCGGCTACAGTCAGCAGCAGCAAGAGAAGATCAAACCGAAGGTGCGTTCGACAGTG 
601  GCGCAGCACCACGAGGCACTGGTGGGCCATGGGTTTACACACGCGCACATCGTTGCGCTCAGCCAACACCCGGCAGCGTTAGGGACCGTCGCTGTCACGT 
701  ATCAGCACATAATCACGGCGTTGCCAGAGGCGACACACGAAGACATCGTTGGCGTCGGCAAACAGTGGTCCGGCGCACGCGCCCTGGAGGCCTTGCTCAC 
801  GGATGCGGGGGAGTTGAGAGGTCCGCCGTTACAGTTGGACACAGGCCAACTTGTGAAGATTGCAAAACGTGGCGGCGTGACCGCAATGGAGGCAGTGCAT 




































Protein sequence of pTN1dnd encoded TALEN 
1    MASSPPKKKRKVSWKDASGWSRMHADPIRPRRPSPARELLPGPQPDRVQPTADRGVSAPAGSPLDGLPAR 
71   RTVSRTRLPSPPAPSPAFSAGSFSDLLRPFDPSLLDTSLLDSMPAVGTPHTAAAPAEWDEAQSALRAADD 
141  PPPTVRVAVTAARPPRAKPAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH 
211  GFTHAHIVALSQHPAALGTVAVTYQHIITALPEATHEDIVGVGKQWSGARALEALLTDAGELRGPPLQLD 
281  TGQLVKIAKRGGVTAMEAVHASRNALTGAPLNLTPDQVVAIASNNGGKQALETVQRLLPVLCQDHGLTPD 
351  QVVAIASNNGGKQALETVQRLLPVLCQDHGLTPDQVVAIASNNGGKQALETVQRLLPVLCQDHGLTPDQV 
421  VAIASNIGGKQALETVQRLLPVLCQDHGLTPDQVVAIASHDGGKQALETVQRLLPVLCQDHGLTPDQVVA 
491  IASNNGGKQALETVQRLLPVLCQDHGLTPDQVVAIASNNGGKQALETVQRLLPVLCQDHGLTPDQVVAIA 
561  SNGGGKQALETVQRLLPVLCQDHGLTPDQVVAIASHDGGKQALETVQRLLPVLCQDHGLTPDQVVAIASH 
631  DGGKQALETVQRLLPVLCQDHGLTPDQVVAIASHDGGKQALETVQRLLPVLCQDHGLTPDQVVAIASHDG 
701  GKQALETVQRLLPVLCQDHGLTPDQVVAIASHDGGKQALETVQRLLPVLCQDHGLTPDQVVAIASNIGGK 
771  QALETVQRLLPVLCQDHGLTPDQVVAIASHDGGKQALETVQRLLPVLCQDHGLTPDQVVAIASHDGGKQA 
841  LESIVAQLSRPDPALAALTNDHLVALACLGGRPAMDAVKKGLPHAPELIRRVNRRIGERTSHRVADYAQV 
911  VRVLEFFQCHSHPAYAFDEAMTQFGMSRNGLVQLFRRVGVTELEARGGTLPPASQRWDRILQASGMKRAK 




1261 EVRRKFNNGEINF  
 
Protein sequence of pTN1dnd encoded TALEN 
1    MASSPPKKKRKVSWKDASGWSRMHADPIRPRRPSPARELLPGPQPDRVQPTADRGVSAPAGSPLDGLPAR 
71   RTVSRTRLPSPPAPSPAFSAGSFSDLLRPFDPSLLDTSLLDSMPAVGTPHTAAAPAEWDEAQSALRAADD 
141  PPPTVRVAVTAARPPRAKPAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH 
211  GFTHAHIVALSQHPAALGTVAVTYQHIITALPEATHEDIVGVGKQWSGARALEALLTDAGELRGPPLQLD 
281  TGQLVKIAKRGGVTAMEAVHASRNALTGAPLNLTPDQVVAIASHDGGKQALETVQRLLPVLCQDHGLTPD 
351  QVVAIASNGGGKQALETVQRLLPVLCQDHGLTPDQVVAIASNNGGKQALETVQRLLPVLCQDHGLTPDQV 
421  VAIASNNGGKQALETVQRLLPVLCQDHGLTPDQVVAIASHDGGKQALETVQRLLPVLCQDHGLTPDQVVA 
491  IASNGGGKQALETVQRLLPVLCQDHGLTPDQVVAIASNNGGKQALETVQRLLPVLCQDHGLTPDQVVAIA 
561  SNIGGKQALETVQRLLPVLCQDHGLTPDQVVAIASNGGGKQALETVQRLLPVLCQDHGLTPDQVVAIASN 
631  IGGKQALETVQRLLPVLCQDHGLTPDQVVAIASNIGGKQALETVQRLLPVLCQDHGLTPDQVVAIASNIG 
701  GKQALETVQRLLPVLCQDHGLTPDQVVAIASNNGGKQALETVQRLLPVLCQDHGLTPDQVVAIASNIGGK 
771  QALETVQRLLPVLCQDHGLTPDQVVAIASHDGGKQALETVQRLLPVLCQDHGLTPDQVVAIASHDGGKQA 
841  LESIVAQLSRPDPALAALTNDHLVALACLGGRPAMDAVKKGLPHAPELIRRVNRRIGERTSHRVADYAQV 
911  VRVLEFFQCHSHPAYAFDEAMTQFGMSRNGLVQLFRRVGVTELEARGGTLPPASQRWDRILQASGMKRAK 
981  PSPTSAQTPDQASLHAFADSLERDLDAPSPMHEGDQTRASSRKRSRSDRAVTGPSAQQAVEVRVPEQRDA 
1051 LHLPLSWRVKRPRTRIWGGLPDPISRSQLVKSELEEKKSELRHKLKYVPHEYIELIEIARNSTQDRILEM 
1121 KVMEFFMKVYGYRGKHLGGSRKPDGAIYTVGSPIDYGVIVDTKAYSGGYNLPIGQADEMQRYVEENQTRN 
1191 KHINPNEWWKVYPSSVTEFKFLFVSGHFKGNYKAQLTRLNHITNCNGAVLSVEELLIGGEMIKAGTLTLE 
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